{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":"2","capability_id":null,"extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"M","per_page":12,"people":[{"id":443976,"version":1,"owner_type":"Person","owner_id":6915,"payload":{"bio":"\u003cp\u003eRyan Majerus is a Partner in the International Trade Team of King \u0026amp; Spalding. His practice covers trade remedies, trade policy and negotiations, trade agreement enforcement, import compliance, supply chains, and government procurement. \u0026nbsp;He has particular experience in the steel, aluminum, automotive, agricultural, and energy industries.\u0026nbsp; He recently performed the functions of the Assistant Secretary for Enforcement and Compliance\u0026nbsp;at the U.S. Department of Commerce, International Trade Administration for over a year, serving as the decisionmaker for every AD/CVD duty imposed by the U.S.\u0026nbsp; He also was the Senior Policy Advisor for Supply Chains at the White House National Economic Council under President Joe Biden, where he played a central role in U.S. industrial strategy.\u0026nbsp;\u0026nbsp;Ryan has been regularly quoted and consulted by major media outlets, including Reuters, Bloomberg, the Washington Post, the New York Times, the Wall Street Journal, Barron\u0026rsquo;s, the Associated Press, AFP, the Detroit Free Press, Pitchbook, Agripulse, and Law360.\u0026nbsp; He has also made TV and radio appearances on the BBC, Street Signs Asia, and Bloomberg Radio.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to his 4 years in political roles at Commerce and the White House, Ryan had a decade-long legal career in the federal government, serving as the Senior Counsel for Appellate And Supreme Court Litigation at the U.S. Department of Agriculture (\u0026ldquo;USDA\u0026rdquo;); as Assistant General Counsel at the Office of the USTR under the first Trump Administration, where he litigated several disputes before the WTO involving U.S. trade remedies and government subsidies and was a lead on agriculture trade policy. He also was a trial attorney in the Civil Division of the DOJ, where he represented Commerce as lead counsel in dozens of trade remedies cases before the U.S. Court of International Trade and the U.S. Court of Appeals for the Federal Circuit, and defended numerous agencies in government contracts and bid protest litigation before the U.S. Court of Federal Claims and Federal Circuit.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eAdmitted in Washington, D.C. and New York.\u0026nbsp;\u003c/em\u003e\u003c/p\u003e","slug":"ryan-majerus","email":"rmajerus@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvised\u003cstrong\u003e\u0026nbsp;manufacturing, technology, energy, consumer, and private equity clients\u003c/strong\u003e\u0026nbsp;on the U.S. Administration\u0026rsquo;s trade and tariff policies.\u003c/p\u003e","\u003cp\u003eAdvised clients on\u0026nbsp;\u003cstrong\u003egovernment procurement, construction, contractual, and M\u0026amp;A issues\u003c/strong\u003e\u0026nbsp;related to international trade, national security, and supply chain resiliency.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003emanufacturing clients\u003c/strong\u003e\u0026nbsp;on trade remedy investigations assessments and enforcement.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3314}]},"expertise":[{"id":579,"guid":"579.smart_tags","index":0,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":1,"source":"capabilities"},{"id":124,"guid":"124.capabilities","index":2,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":3,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":4,"source":"capabilities"},{"id":1147,"guid":"1147.smart_tags","index":5,"source":"smartTags"},{"id":2,"guid":"2.capabilities","index":6,"source":"capabilities"},{"id":116,"guid":"116.capabilities","index":7,"source":"capabilities"},{"id":110,"guid":"110.capabilities","index":8,"source":"capabilities"},{"id":1330,"guid":"1330.smart_tags","index":9,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":10,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":11,"source":"smartTags"},{"id":25,"guid":"25.capabilities","index":12,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":13,"source":"capabilities"},{"id":1689,"guid":"1689.smart_tags","index":14,"source":"smartTags"}],"is_active":true,"last_name":"Majerus","nick_name":"Ryan","clerkships":[{"name":"Law Clerk, Chief Judge McCalla, U.S. District Court for the Western District of Tennessee","years_held":"2010 - 2011"}],"first_name":"Ryan","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2010-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Recipient of the Department of Commerce gold medal for extraordinary efforts in the renegotiation of Section 232 agreements with the EU, UK, and Japan; and in the negotiation of new suspension agreements on a key agricultural product","detail":"Department of Commerce"},{"title":"Recipient of Harry S. Truman Scholarship","detail":"2006"}],"linked_in_url":"www.linkedin.com/in/ryan-majerus-bb114615","seodescription":"Ryan Majerus is a Partner in the International Trade Team of King \u0026 Spalding. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRyan Majerus is a Partner in the International Trade Team of King \u0026amp; Spalding. His practice covers trade remedies, trade policy and negotiations, trade agreement enforcement, import compliance, supply chains, and government procurement. \u0026nbsp;He has particular experience in the steel, aluminum, automotive, agricultural, and energy industries.\u0026nbsp; He recently performed the functions of the Assistant Secretary for Enforcement and Compliance\u0026nbsp;at the U.S. Department of Commerce, International Trade Administration for over a year, serving as the decisionmaker for every AD/CVD duty imposed by the U.S.\u0026nbsp; He also was the Senior Policy Advisor for Supply Chains at the White House National Economic Council under President Joe Biden, where he played a central role in U.S. industrial strategy.\u0026nbsp;\u0026nbsp;Ryan has been regularly quoted and consulted by major media outlets, including Reuters, Bloomberg, the Washington Post, the New York Times, the Wall Street Journal, Barron\u0026rsquo;s, the Associated Press, AFP, the Detroit Free Press, Pitchbook, Agripulse, and Law360.\u0026nbsp; He has also made TV and radio appearances on the BBC, Street Signs Asia, and Bloomberg Radio.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to his 4 years in political roles at Commerce and the White House, Ryan had a decade-long legal career in the federal government, serving as the Senior Counsel for Appellate And Supreme Court Litigation at the U.S. Department of Agriculture (\u0026ldquo;USDA\u0026rdquo;); as Assistant General Counsel at the Office of the USTR under the first Trump Administration, where he litigated several disputes before the WTO involving U.S. trade remedies and government subsidies and was a lead on agriculture trade policy. He also was a trial attorney in the Civil Division of the DOJ, where he represented Commerce as lead counsel in dozens of trade remedies cases before the U.S. Court of International Trade and the U.S. Court of Appeals for the Federal Circuit, and defended numerous agencies in government contracts and bid protest litigation before the U.S. Court of Federal Claims and Federal Circuit.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eAdmitted in Washington, D.C. and New York.\u0026nbsp;\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003eAdvised\u003cstrong\u003e\u0026nbsp;manufacturing, technology, energy, consumer, and private equity clients\u003c/strong\u003e\u0026nbsp;on the U.S. Administration\u0026rsquo;s trade and tariff policies.\u003c/p\u003e","\u003cp\u003eAdvised clients on\u0026nbsp;\u003cstrong\u003egovernment procurement, construction, contractual, and M\u0026amp;A issues\u003c/strong\u003e\u0026nbsp;related to international trade, national security, and supply chain resiliency.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003emanufacturing clients\u003c/strong\u003e\u0026nbsp;on trade remedy investigations assessments and enforcement.\u003c/p\u003e"],"recognitions":[{"title":"Recipient of the Department of Commerce gold medal for extraordinary efforts in the renegotiation of Section 232 agreements with the EU, UK, and Japan; and in the negotiation of new suspension agreements on a key agricultural product","detail":"Department of Commerce"},{"title":"Recipient of Harry S. Truman Scholarship","detail":"2006"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12430}]},"capability_group_id":2},"created_at":"2025-12-05T05:02:15.000Z","updated_at":"2025-12-05T05:02:15.000Z","searchable_text":"Majerus{{ FIELD }}{:title=\u0026gt;\"Recipient of the Department of Commerce gold medal for extraordinary efforts in the renegotiation of Section 232 agreements with the EU, UK, and Japan; and in the negotiation of new suspension agreements on a key agricultural product\", :detail=\u0026gt;\"Department of Commerce\"}{{ FIELD }}{:title=\u0026gt;\"Recipient of Harry S. Truman Scholarship\", :detail=\u0026gt;\"2006\"}{{ FIELD }}Advised manufacturing, technology, energy, consumer, and private equity clients on the U.S. Administration’s trade and tariff policies.{{ FIELD }}Advised clients on government procurement, construction, contractual, and M\u0026amp;A issues related to international trade, national security, and supply chain resiliency.{{ FIELD }}Advised manufacturing clients on trade remedy investigations assessments and enforcement.{{ FIELD }}Ryan Majerus is a Partner in the International Trade Team of King \u0026amp; Spalding. His practice covers trade remedies, trade policy and negotiations, trade agreement enforcement, import compliance, supply chains, and government procurement.  He has particular experience in the steel, aluminum, automotive, agricultural, and energy industries.  He recently performed the functions of the Assistant Secretary for Enforcement and Compliance at the U.S. Department of Commerce, International Trade Administration for over a year, serving as the decisionmaker for every AD/CVD duty imposed by the U.S.  He also was the Senior Policy Advisor for Supply Chains at the White House National Economic Council under President Joe Biden, where he played a central role in U.S. industrial strategy.  Ryan has been regularly quoted and consulted by major media outlets, including Reuters, Bloomberg, the Washington Post, the New York Times, the Wall Street Journal, Barron’s, the Associated Press, AFP, the Detroit Free Press, Pitchbook, Agripulse, and Law360.  He has also made TV and radio appearances on the BBC, Street Signs Asia, and Bloomberg Radio.\nPrior to his 4 years in political roles at Commerce and the White House, Ryan had a decade-long legal career in the federal government, serving as the Senior Counsel for Appellate And Supreme Court Litigation at the U.S. Department of Agriculture (“USDA”); as Assistant General Counsel at the Office of the USTR under the first Trump Administration, where he litigated several disputes before the WTO involving U.S. trade remedies and government subsidies and was a lead on agriculture trade policy. He also was a trial attorney in the Civil Division of the DOJ, where he represented Commerce as lead counsel in dozens of trade remedies cases before the U.S. Court of International Trade and the U.S. Court of Appeals for the Federal Circuit, and defended numerous agencies in government contracts and bid protest litigation before the U.S. Court of Federal Claims and Federal Circuit.\nAdmitted in Washington, D.C. and New York.  Ryan Majerus lawyer Partner Recipient of the Department of Commerce gold medal for extraordinary efforts in the renegotiation of Section 232 agreements with the EU, UK, and Japan; and in the negotiation of new suspension agreements on a key agricultural product Department of Commerce Recipient of Harry S. Truman Scholarship 2006 Georgetown University  Georgetown University Georgetown University Law Center District of Columbia New York Washington International Trade Association Committee to Enforce the U.S. Trade Laws Editor-in-Chief of the Georgetown Journal of International Law Law Clerk, Chief Judge McCalla, U.S. District Court for the Western District of Tennessee Advised manufacturing, technology, energy, consumer, and private equity clients on the U.S. Administration’s trade and tariff policies. Advised clients on government procurement, construction, contractual, and M\u0026amp;A issues related to international trade, national security, and supply chain resiliency. Advised manufacturing clients on trade remedy investigations assessments and enforcement.","searchable_name":"Ryan Majerus","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442384,"version":1,"owner_type":"Person","owner_id":966,"payload":{"bio":"\u003cp\u003eChris Markus focuses on U.S. federal and state regulation of drugs, biologics, biotechnology and related products. As a partner in our FDA and Life Sciences practice and Deputy Practice Group Leader, Chris represents clients in a range of regulatory strategy and compliance evaluations, enforcement matters, and business transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChris represents drug, biologic and other healthcare products companies and investors with compliance and enforcement under the Food and Drug Administration, the Drug Enforcement Administration (DEA) and related state agencies such as Boards of Pharmacy. She also represents clients in business transactions, including strategic planning, due diligence and assessment, that involve product development and approval, safety, labeling, marketing and advertising, manufacturing and supply chain.\u003c/p\u003e\n\u003cp\u003eBased on her experience, Chris was chosen to serve as the legal member of the Institute of Medicine's Committee on Pediatric Studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. IOM evaluated studies of drugs and biologics performed under two statutory regimes that provide incentives and, in some instances, mandate pediatric research through the drug approval process. The Committee assessed the findings and offered recommendations and briefings to FDA and the U.S. Congress.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChris has been recognized by the\u0026nbsp;\u003cem\u003eBTI Consulting Group\u003c/em\u003e\u0026nbsp;as a 2017 \"Client Service All-Star\" and named repeatedly as a \"Life Sciences Star\" by\u0026nbsp;\u003cem\u003eLMG Life Sciences.\u003c/em\u003e\u0026nbsp; She continues to be identified as one of\u0026nbsp;\u003cem\u003eThe Best Lawyers in America\u003c/em\u003e\u0026nbsp;for FDA Law, and ranked as a life sciences practitioner by\u0026nbsp;\u003cem\u003eThe Legal 500\u003c/em\u003e.\u003c/p\u003e","slug":"christina-markus","email":"cmarkus@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvised numerous pharmaceutical and device manufacturers and distributors on compliance with\u0026nbsp;\u003cstrong\u003estate laws\u003c/strong\u003e\u0026nbsp;governing operating entity licensure (including for \"virtual\" companies), extended producer responsibility (drug and sharps take back laws) and product distribution monitoring and reporting.\u003c/p\u003e","\u003cp\u003eAdvised on range of clinical trial issues, including design, compliance and transparency disclosures.\u003c/p\u003e","\u003cp\u003eDeveloped responses to inspectional findings and import alerts, in close collaboration with technical experts.\u003c/p\u003e","\u003cp\u003eAdvised on the Prescription Drug Marketing Act (PDMA) and state-specific requirements concerning the distribution and reporting of prescription, over-the-counter, and controlled drug samples.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003edozens of pharmaceutical and biological product companies\u003c/strong\u003e, and investors, on life cycle issues, including patent and market exclusivity eligibility, regulatory strategies, and transactional diligence.\u003c/p\u003e","\u003cp\u003eDeveloped and responded to citizen petition elucidating legal and scientific concerns about FDA's proposed\u0026nbsp;\u003cstrong\u003ebioequivalence standards, Hatch-Waxman 30-month stay provisions\u003c/strong\u003e, and other key regulatory topics.\u003c/p\u003e","\u003cp\u003ePerformed due diligence for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eregulatory issues\u003c/strong\u003e\u0026nbsp;and supported negotiation for corporate licensing, M\u0026amp;A, equity investing and financial institution lending.\u003c/p\u003e","\u003cp\u003eEvaluated\u0026nbsp;\u003cstrong\u003eimpacts of the Drug Supply Chain Security Act (DSCSA)\u003c/strong\u003e\u0026nbsp;on manufacturers, distributors, and third-party logistics providers of drugs, medical devices and combination products.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eproduct distributors\u003c/strong\u003e\u0026nbsp;against proposed disciplinary action by the California Board of Pharmacy; Alabama Board of Pharmacy, and other jurisdictions.\u003c/p\u003e","\u003cp\u003eAdvised on the status and use of controlled substances\u0026nbsp;\u003cstrong\u003eand listed chemicals\u003c/strong\u003e, including:\u003c/p\u003e\n\u003cp\u003e- Administrative hearings concerning applicants for registration to import narcotic raw materials,\u003c/p\u003e\n\u003cp\u003e- Representation of a reverse distributor before DEA and state agencies to untangle registration issues arising in a multi-faceted corporate transaction, without penalty to the acquiring company,\u003c/p\u003e\n\u003cp\u003e- Applied listed chemical requirements impacting an industrial chemical importer's supply chain, and\u003c/p\u003e\n\u003cp\u003e- Facilitated DEA scheduling of a new chemical entity completing the FDA approval process.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.smart_tags","index":1,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":3,"source":"smartTags"},{"id":105,"guid":"105.capabilities","index":4,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":5,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":6,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":7,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":10,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":11,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":12,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":13,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":14,"source":"smartTags"}],"is_active":true,"last_name":"Markus","nick_name":"Chris","clerkships":[],"first_name":"Christina","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Client Service All-Star (unprompted survey of large company corporate counsel)","detail":"BTI Consulting, 2017"},{"title":"Who's Who Legal: Life Sciences","detail":"2017-2024"},{"title":"Leading Life Sciences Lawyer","detail":"LMG Life Sciences, 2012-2025"},{"title":"Best Lawyers in America - FDA Law","detail":"Best Lawyers/US News \u0026 World Report, 2015-2026"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Markus focuses on U.S. federal and state regulation of drugs, biologics, biotechnology and related products. As a partner in our FDA and Life Sciences practice and Deputy Practice Group Leader, Chris represents clients in a range of regulatory strategy and compliance evaluations, enforcement matters, and business transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChris represents drug, biologic and other healthcare products companies and investors with compliance and enforcement under the Food and Drug Administration, the Drug Enforcement Administration (DEA) and related state agencies such as Boards of Pharmacy. She also represents clients in business transactions, including strategic planning, due diligence and assessment, that involve product development and approval, safety, labeling, marketing and advertising, manufacturing and supply chain.\u003c/p\u003e\n\u003cp\u003eBased on her experience, Chris was chosen to serve as the legal member of the Institute of Medicine's Committee on Pediatric Studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. IOM evaluated studies of drugs and biologics performed under two statutory regimes that provide incentives and, in some instances, mandate pediatric research through the drug approval process. The Committee assessed the findings and offered recommendations and briefings to FDA and the U.S. Congress.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChris has been recognized by the\u0026nbsp;\u003cem\u003eBTI Consulting Group\u003c/em\u003e\u0026nbsp;as a 2017 \"Client Service All-Star\" and named repeatedly as a \"Life Sciences Star\" by\u0026nbsp;\u003cem\u003eLMG Life Sciences.\u003c/em\u003e\u0026nbsp; She continues to be identified as one of\u0026nbsp;\u003cem\u003eThe Best Lawyers in America\u003c/em\u003e\u0026nbsp;for FDA Law, and ranked as a life sciences practitioner by\u0026nbsp;\u003cem\u003eThe Legal 500\u003c/em\u003e.\u003c/p\u003e","matters":["\u003cp\u003eAdvised numerous pharmaceutical and device manufacturers and distributors on compliance with\u0026nbsp;\u003cstrong\u003estate laws\u003c/strong\u003e\u0026nbsp;governing operating entity licensure (including for \"virtual\" companies), extended producer responsibility (drug and sharps take back laws) and product distribution monitoring and reporting.\u003c/p\u003e","\u003cp\u003eAdvised on range of clinical trial issues, including design, compliance and transparency disclosures.\u003c/p\u003e","\u003cp\u003eDeveloped responses to inspectional findings and import alerts, in close collaboration with technical experts.\u003c/p\u003e","\u003cp\u003eAdvised on the Prescription Drug Marketing Act (PDMA) and state-specific requirements concerning the distribution and reporting of prescription, over-the-counter, and controlled drug samples.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003edozens of pharmaceutical and biological product companies\u003c/strong\u003e, and investors, on life cycle issues, including patent and market exclusivity eligibility, regulatory strategies, and transactional diligence.\u003c/p\u003e","\u003cp\u003eDeveloped and responded to citizen petition elucidating legal and scientific concerns about FDA's proposed\u0026nbsp;\u003cstrong\u003ebioequivalence standards, Hatch-Waxman 30-month stay provisions\u003c/strong\u003e, and other key regulatory topics.\u003c/p\u003e","\u003cp\u003ePerformed due diligence for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eregulatory issues\u003c/strong\u003e\u0026nbsp;and supported negotiation for corporate licensing, M\u0026amp;A, equity investing and financial institution lending.\u003c/p\u003e","\u003cp\u003eEvaluated\u0026nbsp;\u003cstrong\u003eimpacts of the Drug Supply Chain Security Act (DSCSA)\u003c/strong\u003e\u0026nbsp;on manufacturers, distributors, and third-party logistics providers of drugs, medical devices and combination products.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eproduct distributors\u003c/strong\u003e\u0026nbsp;against proposed disciplinary action by the California Board of Pharmacy; Alabama Board of Pharmacy, and other jurisdictions.\u003c/p\u003e","\u003cp\u003eAdvised on the status and use of controlled substances\u0026nbsp;\u003cstrong\u003eand listed chemicals\u003c/strong\u003e, including:\u003c/p\u003e\n\u003cp\u003e- Administrative hearings concerning applicants for registration to import narcotic raw materials,\u003c/p\u003e\n\u003cp\u003e- Representation of a reverse distributor before DEA and state agencies to untangle registration issues arising in a multi-faceted corporate transaction, without penalty to the acquiring company,\u003c/p\u003e\n\u003cp\u003e- Applied listed chemical requirements impacting an industrial chemical importer's supply chain, and\u003c/p\u003e\n\u003cp\u003e- Facilitated DEA scheduling of a new chemical entity completing the FDA approval process.\u003c/p\u003e"],"recognitions":[{"title":"Client Service All-Star (unprompted survey of large company corporate counsel)","detail":"BTI Consulting, 2017"},{"title":"Who's Who Legal: Life Sciences","detail":"2017-2024"},{"title":"Leading Life Sciences Lawyer","detail":"LMG Life Sciences, 2012-2025"},{"title":"Best Lawyers in America - FDA Law","detail":"Best Lawyers/US News \u0026 World Report, 2015-2026"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1035}]},"capability_group_id":2},"created_at":"2025-11-05T05:04:00.000Z","updated_at":"2025-11-05T05:04:00.000Z","searchable_text":"Markus{{ FIELD }}{:title=\u0026gt;\"Client Service All-Star (unprompted survey of large company corporate counsel)\", :detail=\u0026gt;\"BTI Consulting, 2017\"}{{ FIELD }}{:title=\u0026gt;\"Who's Who Legal: Life Sciences\", :detail=\u0026gt;\"2017-2024\"}{{ FIELD }}{:title=\u0026gt;\"Leading Life Sciences Lawyer\", :detail=\u0026gt;\"LMG Life Sciences, 2012-2025\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America - FDA Law\", :detail=\u0026gt;\"Best Lawyers/US News \u0026amp; World Report, 2015-2026\"}{{ FIELD }}Advised numerous pharmaceutical and device manufacturers and distributors on compliance with state laws governing operating entity licensure (including for \"virtual\" companies), extended producer responsibility (drug and sharps take back laws) and product distribution monitoring and reporting.{{ FIELD }}Advised on range of clinical trial issues, including design, compliance and transparency disclosures.{{ FIELD }}Developed responses to inspectional findings and import alerts, in close collaboration with technical experts.{{ FIELD }}Advised on the Prescription Drug Marketing Act (PDMA) and state-specific requirements concerning the distribution and reporting of prescription, over-the-counter, and controlled drug samples.{{ FIELD }}Advised dozens of pharmaceutical and biological product companies, and investors, on life cycle issues, including patent and market exclusivity eligibility, regulatory strategies, and transactional diligence.{{ FIELD }}Developed and responded to citizen petition elucidating legal and scientific concerns about FDA's proposed bioequivalence standards, Hatch-Waxman 30-month stay provisions, and other key regulatory topics.{{ FIELD }}Performed due diligence for regulatory issues and supported negotiation for corporate licensing, M\u0026amp;A, equity investing and financial institution lending.{{ FIELD }}Evaluated impacts of the Drug Supply Chain Security Act (DSCSA) on manufacturers, distributors, and third-party logistics providers of drugs, medical devices and combination products.{{ FIELD }}Defended product distributors against proposed disciplinary action by the California Board of Pharmacy; Alabama Board of Pharmacy, and other jurisdictions.{{ FIELD }}Advised on the status and use of controlled substances and listed chemicals, including:\n- Administrative hearings concerning applicants for registration to import narcotic raw materials,\n- Representation of a reverse distributor before DEA and state agencies to untangle registration issues arising in a multi-faceted corporate transaction, without penalty to the acquiring company,\n- Applied listed chemical requirements impacting an industrial chemical importer's supply chain, and\n- Facilitated DEA scheduling of a new chemical entity completing the FDA approval process.{{ FIELD }}Chris Markus focuses on U.S. federal and state regulation of drugs, biologics, biotechnology and related products. As a partner in our FDA and Life Sciences practice and Deputy Practice Group Leader, Chris represents clients in a range of regulatory strategy and compliance evaluations, enforcement matters, and business transactions.\nChris represents drug, biologic and other healthcare products companies and investors with compliance and enforcement under the Food and Drug Administration, the Drug Enforcement Administration (DEA) and related state agencies such as Boards of Pharmacy. She also represents clients in business transactions, including strategic planning, due diligence and assessment, that involve product development and approval, safety, labeling, marketing and advertising, manufacturing and supply chain.\nBased on her experience, Chris was chosen to serve as the legal member of the Institute of Medicine's Committee on Pediatric Studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. IOM evaluated studies of drugs and biologics performed under two statutory regimes that provide incentives and, in some instances, mandate pediatric research through the drug approval process. The Committee assessed the findings and offered recommendations and briefings to FDA and the U.S. Congress. \nChris has been recognized by the BTI Consulting Group as a 2017 \"Client Service All-Star\" and named repeatedly as a \"Life Sciences Star\" by LMG Life Sciences.  She continues to be identified as one of The Best Lawyers in America for FDA Law, and ranked as a life sciences practitioner by The Legal 500. Partner Client Service All-Star (unprompted survey of large company corporate counsel) BTI Consulting, 2017 Who's Who Legal: Life Sciences 2017-2024 Leading Life Sciences Lawyer LMG Life Sciences, 2012-2025 Best Lawyers in America - FDA Law Best Lawyers/US News \u0026amp; World Report, 2015-2026 College of William and Mary William \u0026amp; Mary Law School University of Virginia University of Virginia School of Law District of Columbia Virginia The District of Columbia Bar Virginia State Bar Advised numerous pharmaceutical and device manufacturers and distributors on compliance with state laws governing operating entity licensure (including for \"virtual\" companies), extended producer responsibility (drug and sharps take back laws) and product distribution monitoring and reporting. Advised on range of clinical trial issues, including design, compliance and transparency disclosures. Developed responses to inspectional findings and import alerts, in close collaboration with technical experts. Advised on the Prescription Drug Marketing Act (PDMA) and state-specific requirements concerning the distribution and reporting of prescription, over-the-counter, and controlled drug samples. Advised dozens of pharmaceutical and biological product companies, and investors, on life cycle issues, including patent and market exclusivity eligibility, regulatory strategies, and transactional diligence. Developed and responded to citizen petition elucidating legal and scientific concerns about FDA's proposed bioequivalence standards, Hatch-Waxman 30-month stay provisions, and other key regulatory topics. Performed due diligence for regulatory issues and supported negotiation for corporate licensing, M\u0026amp;A, equity investing and financial institution lending. Evaluated impacts of the Drug Supply Chain Security Act (DSCSA) on manufacturers, distributors, and third-party logistics providers of drugs, medical devices and combination products. Defended product distributors against proposed disciplinary action by the California Board of Pharmacy; Alabama Board of Pharmacy, and other jurisdictions. Advised on the status and use of controlled substances and listed chemicals, including:\n- Administrative hearings concerning applicants for registration to import narcotic raw materials,\n- Representation of a reverse distributor before DEA and state agencies to untangle registration issues arising in a multi-faceted corporate transaction, without penalty to the acquiring company,\n- Applied listed chemical requirements impacting an industrial chemical importer's supply chain, and\n- Facilitated DEA scheduling of a new chemical entity completing the FDA approval process.","searchable_name":"Christina M. Markus (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444226,"version":1,"owner_type":"Person","owner_id":3179,"payload":{"bio":"\u003cp\u003eDavid Mattern\u0026nbsp;is an experienced trial and appellate lawyer who represents technology, media, and entertainment companies in complex litigation and intellectual property matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDavid has substantial experience defending technology platforms and other companies in suits related to user content, including in copyright litigation, matters involving Section 230, the DMCA, and trademark and trade secret claims.\u0026nbsp; David has also litigated\u0026nbsp;consumer class actions, securities cases,\u0026nbsp;and constitutional matters.\u003c/p\u003e\n\u003cp\u003eBefore rejoining King \u0026amp; Spalding, David was a law clerk to then-Chief Judge R. Guy Cole (Sixth Circuit). He received his J.D. from Columbia Law School, where he was a James Kent Scholar.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDavid has represented clients at trial and appeal in courts across the country. David has particular expertise in copyright law and platform defenses, including representing platforms in copyright litigation and\u0026nbsp;rate court disputes, and in defending platforms in suits related to user content and content moderation under the DMCA and Section 230.\u0026nbsp;His experience extends to a wide range of subject areas, including False Claims Act litigation,\u0026nbsp;product liability litigation, professional liability litigation, and many other types of business litigation.\u003c/p\u003e\n\u003cp\u003eDavid devotes a significant amount of time to pro bono civil rights litigation. Recent successful representations include obtaining reversal of a grant of qualified immunity to prison officials in a suit brought under Section 1983 in a case he argued in the Ninth Circuit, and in obtaining a reversal of a grant of summary judgment to prison officials on exhaustion under the PLRA in a case he argued in the Seventh Circuit.\u0026nbsp;\u003c/p\u003e","slug":"david-mattern","email":"dmattern@kslaw.com","phone":null,"matters":["\u003cp\u003eCo-Lead Counsel to \u003cstrong\u003eTikTok \u003c/strong\u003ein nationwide litigation in which personal injuries and school districts plaintiffs allege harms arising from adolescent use of social media and entertainment platforms, including in the Social Media MDL pending in N.D. Cal. and JCCP pending in Los Angeles Superior Court. Runner-up for Litigator of the Week for obtaining dismissal of school district suits in the JCCP proceeding.\u003c/p\u003e","\u003cp\u003eCounsel to \u003cstrong\u003eActivision Blizzard\u003c/strong\u003e in connection with nationwide lawsuits alleging a variety of harms arising from the purported addiction to video games.\u003c/p\u003e","\u003cp\u003eCo-lead Counsel to the \u003cstrong\u003eRadio Music License Committee \u003c/strong\u003ein a series of rate-setting proceedings involving the performing rights\u0026rsquo; organizations ASCAP, BMI, and SESAC\u003c/p\u003e","\u003cp\u003eCounsel to \u003cstrong\u003eGoogle/YouTube\u003c/strong\u003e in a rate-setting proceeding before the Copyright Royalty Board to determine the rates non-interactive streaming services pay record labels, including arguing on behalf of \u003cstrong\u003eGoogle/YouTube \u003c/strong\u003ein the D.C. Circuit in support of affirming the rate determination\u003c/p\u003e","\u003cp\u003eRepresented a \u003cstrong\u003elarge technology company\u003c/strong\u003e in litigation filed against Russian cybercriminals operating a botnet that employed blockchain technology.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eDowntown v. Peloton\u0026nbsp;\u003c/em\u003e(2019).\u003c/strong\u003e\u0026nbsp;Represents Peloton Interactive, Inc. in suit brought by music publishers in SDNY\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePhonorecords III\u0026nbsp;\u003c/em\u003e(2017).\u003c/strong\u003e\u0026nbsp;Represented Google before the Copyright Royalty Board in a proceeding to set the royalty rates paid to publishers for interactive streaming.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePandora v. BMI\u0026nbsp;\u003c/em\u003e(2015).\u0026nbsp;\u003c/strong\u003eMember of trial team representing Pandora against Broadcast Music, Inc. in rate court proceeding under antitrust consent decree to determine public performance royalties for Pandora\u0026rsquo;s internet radio service.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":7,"source":"capabilities"},{"id":1233,"guid":"1233.smart_tags","index":8,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":9,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Mattern","nick_name":"David","clerkships":[{"name":"Judicial Clerk, Chief Judge R. Guy Cole, U.S. Court of Appeals for the Sixth Circuit","years_held":"2017 - 2018"}],"first_name":"David","title_rank":9999,"updated_by":35,"law_schools":[{"id":485,"meta":{"degree":"J.D.","honors":"James Kent Scholar","is_law_school":1,"graduation_date":"2013-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"P.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDavid Mattern\u0026nbsp;is an experienced trial and appellate lawyer who represents technology, media, and entertainment companies in complex litigation and intellectual property matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDavid has substantial experience defending technology platforms and other companies in suits related to user content, including in copyright litigation, matters involving Section 230, the DMCA, and trademark and trade secret claims.\u0026nbsp; David has also litigated\u0026nbsp;consumer class actions, securities cases,\u0026nbsp;and constitutional matters.\u003c/p\u003e\n\u003cp\u003eBefore rejoining King \u0026amp; Spalding, David was a law clerk to then-Chief Judge R. Guy Cole (Sixth Circuit). He received his J.D. from Columbia Law School, where he was a James Kent Scholar.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDavid has represented clients at trial and appeal in courts across the country. David has particular expertise in copyright law and platform defenses, including representing platforms in copyright litigation and\u0026nbsp;rate court disputes, and in defending platforms in suits related to user content and content moderation under the DMCA and Section 230.\u0026nbsp;His experience extends to a wide range of subject areas, including False Claims Act litigation,\u0026nbsp;product liability litigation, professional liability litigation, and many other types of business litigation.\u003c/p\u003e\n\u003cp\u003eDavid devotes a significant amount of time to pro bono civil rights litigation. Recent successful representations include obtaining reversal of a grant of qualified immunity to prison officials in a suit brought under Section 1983 in a case he argued in the Ninth Circuit, and in obtaining a reversal of a grant of summary judgment to prison officials on exhaustion under the PLRA in a case he argued in the Seventh Circuit.\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eCo-Lead Counsel to \u003cstrong\u003eTikTok \u003c/strong\u003ein nationwide litigation in which personal injuries and school districts plaintiffs allege harms arising from adolescent use of social media and entertainment platforms, including in the Social Media MDL pending in N.D. Cal. and JCCP pending in Los Angeles Superior Court. Runner-up for Litigator of the Week for obtaining dismissal of school district suits in the JCCP proceeding.\u003c/p\u003e","\u003cp\u003eCounsel to \u003cstrong\u003eActivision Blizzard\u003c/strong\u003e in connection with nationwide lawsuits alleging a variety of harms arising from the purported addiction to video games.\u003c/p\u003e","\u003cp\u003eCo-lead Counsel to the \u003cstrong\u003eRadio Music License Committee \u003c/strong\u003ein a series of rate-setting proceedings involving the performing rights\u0026rsquo; organizations ASCAP, BMI, and SESAC\u003c/p\u003e","\u003cp\u003eCounsel to \u003cstrong\u003eGoogle/YouTube\u003c/strong\u003e in a rate-setting proceeding before the Copyright Royalty Board to determine the rates non-interactive streaming services pay record labels, including arguing on behalf of \u003cstrong\u003eGoogle/YouTube \u003c/strong\u003ein the D.C. Circuit in support of affirming the rate determination\u003c/p\u003e","\u003cp\u003eRepresented a \u003cstrong\u003elarge technology company\u003c/strong\u003e in litigation filed against Russian cybercriminals operating a botnet that employed blockchain technology.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eDowntown v. Peloton\u0026nbsp;\u003c/em\u003e(2019).\u003c/strong\u003e\u0026nbsp;Represents Peloton Interactive, Inc. in suit brought by music publishers in SDNY\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePhonorecords III\u0026nbsp;\u003c/em\u003e(2017).\u003c/strong\u003e\u0026nbsp;Represented Google before the Copyright Royalty Board in a proceeding to set the royalty rates paid to publishers for interactive streaming.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePandora v. BMI\u0026nbsp;\u003c/em\u003e(2015).\u0026nbsp;\u003c/strong\u003eMember of trial team representing Pandora against Broadcast Music, Inc. in rate court proceeding under antitrust consent decree to determine public performance royalties for Pandora\u0026rsquo;s internet radio service.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9106}]},"capability_group_id":3},"created_at":"2025-12-12T21:52:12.000Z","updated_at":"2025-12-12T21:52:12.000Z","searchable_text":"Mattern{{ FIELD }}Co-Lead Counsel to TikTok in nationwide litigation in which personal injuries and school districts plaintiffs allege harms arising from adolescent use of social media and entertainment platforms, including in the Social Media MDL pending in N.D. Cal. and JCCP pending in Los Angeles Superior Court. Runner-up for Litigator of the Week for obtaining dismissal of school district suits in the JCCP proceeding.{{ FIELD }}Counsel to Activision Blizzard in connection with nationwide lawsuits alleging a variety of harms arising from the purported addiction to video games.{{ FIELD }}Co-lead Counsel to the Radio Music License Committee in a series of rate-setting proceedings involving the performing rights’ organizations ASCAP, BMI, and SESAC{{ FIELD }}Counsel to Google/YouTube in a rate-setting proceeding before the Copyright Royalty Board to determine the rates non-interactive streaming services pay record labels, including arguing on behalf of Google/YouTube in the D.C. Circuit in support of affirming the rate determination{{ FIELD }}Represented a large technology company in litigation filed against Russian cybercriminals operating a botnet that employed blockchain technology.{{ FIELD }}Downtown v. Peloton (2019). Represents Peloton Interactive, Inc. in suit brought by music publishers in SDNY{{ FIELD }}Phonorecords III (2017). Represented Google before the Copyright Royalty Board in a proceeding to set the royalty rates paid to publishers for interactive streaming.{{ FIELD }}Pandora v. BMI (2015). Member of trial team representing Pandora against Broadcast Music, Inc. in rate court proceeding under antitrust consent decree to determine public performance royalties for Pandora’s internet radio service.{{ FIELD }}David Mattern is an experienced trial and appellate lawyer who represents technology, media, and entertainment companies in complex litigation and intellectual property matters.  \nDavid has substantial experience defending technology platforms and other companies in suits related to user content, including in copyright litigation, matters involving Section 230, the DMCA, and trademark and trade secret claims.  David has also litigated consumer class actions, securities cases, and constitutional matters.\nBefore rejoining King \u0026amp; Spalding, David was a law clerk to then-Chief Judge R. Guy Cole (Sixth Circuit). He received his J.D. from Columbia Law School, where he was a James Kent Scholar. \nDavid has represented clients at trial and appeal in courts across the country. David has particular expertise in copyright law and platform defenses, including representing platforms in copyright litigation and rate court disputes, and in defending platforms in suits related to user content and content moderation under the DMCA and Section 230. His experience extends to a wide range of subject areas, including False Claims Act litigation, product liability litigation, professional liability litigation, and many other types of business litigation.\nDavid devotes a significant amount of time to pro bono civil rights litigation. Recent successful representations include obtaining reversal of a grant of qualified immunity to prison officials in a suit brought under Section 1983 in a case he argued in the Ninth Circuit, and in obtaining a reversal of a grant of summary judgment to prison officials on exhaustion under the PLRA in a case he argued in the Seventh Circuit.  Partner Case Western Reserve University Case Western Reserve University School of Law Columbia University Columbia University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Columbia District of Columbia New York Judicial Clerk, Chief Judge R. Guy Cole, U.S. Court of Appeals for the Sixth Circuit Co-Lead Counsel to TikTok in nationwide litigation in which personal injuries and school districts plaintiffs allege harms arising from adolescent use of social media and entertainment platforms, including in the Social Media MDL pending in N.D. Cal. and JCCP pending in Los Angeles Superior Court. Runner-up for Litigator of the Week for obtaining dismissal of school district suits in the JCCP proceeding. Counsel to Activision Blizzard in connection with nationwide lawsuits alleging a variety of harms arising from the purported addiction to video games. Co-lead Counsel to the Radio Music License Committee in a series of rate-setting proceedings involving the performing rights’ organizations ASCAP, BMI, and SESAC Counsel to Google/YouTube in a rate-setting proceeding before the Copyright Royalty Board to determine the rates non-interactive streaming services pay record labels, including arguing on behalf of Google/YouTube in the D.C. Circuit in support of affirming the rate determination Represented a large technology company in litigation filed against Russian cybercriminals operating a botnet that employed blockchain technology. Downtown v. Peloton (2019). Represents Peloton Interactive, Inc. in suit brought by music publishers in SDNY Phonorecords III (2017). Represented Google before the Copyright Royalty Board in a proceeding to set the royalty rates paid to publishers for interactive streaming. Pandora v. BMI (2015). Member of trial team representing Pandora against Broadcast Music, Inc. in rate court proceeding under antitrust consent decree to determine public performance royalties for Pandora’s internet radio service.","searchable_name":"David P. Mattern","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":426447,"version":1,"owner_type":"Person","owner_id":3575,"payload":{"bio":"\u003cp\u003eTucker McCarthy is a Partner with King \u0026amp; Spalding's Real Estate and Banking and Institutional Finance practices.\u0026nbsp; Resident in the Washington, D.C. office, Tucker represents lenders and borrowers in various secured lending transactions, with a focus on commercial real estate finance and leveraged finance.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTucker\u0026nbsp;holds a Bachelor of Arts in English from Colgate University, where he graduated\u0026nbsp;\u003cem\u003emagna cum laude\u003c/em\u003e\u0026nbsp;with high honors in English Literature. He earned his J.D. from Wake Forest University School of Law and a Masters of Laws in Banking Law and Financial Regulation from the London School of Economics and Political Science.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Tucker\u0026nbsp;served as clerk to the Honorable Denise K. Vowell and the Honorable Christian J. Moran, both of the U.S. Court of Federal Claims Office of Special Masters which adjudicates vaccine injury claims brought under the National Childhood Vaccine Injury Act of 1986.\u003c/p\u003e","slug":"tucker-mccarthy","email":"tmccarthy@kslaw.com","phone":null,"matters":["\u003cp\u003eThe sole lender in connection with the recapitalization of a luxury Miami hotel.\u003c/p\u003e","\u003cp\u003eThe administrative agent in connection with the construction and development of mixed-use properties in Florida and California.\u003c/p\u003e","\u003cp\u003eA private wealth lender with respect to loans made to a high-net-worth individuals for the purchase of homes in New York and Montana and the construction of a luxury yacht.\u003c/p\u003e","\u003cp\u003eThe administrative agent in connection with the financing of a rapidly-expanding national restaurant chain.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":734,"guid":"734.smart_tags","index":0,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":2,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":3,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":4,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":5,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":6,"source":"capabilities"},{"id":1261,"guid":"1261.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"McCarthy","nick_name":"Tucker","clerkships":[{"name":"Law Clerk, Special Masters Denise K. Vowell and Christian J. Moran, U.S. Court of Federal Claims","years_held":"2012-2014"}],"first_name":"Tucker","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"W.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eTucker McCarthy is a Partner with King \u0026amp; Spalding's Real Estate and Banking and Institutional Finance practices.\u0026nbsp; Resident in the Washington, D.C. office, Tucker represents lenders and borrowers in various secured lending transactions, with a focus on commercial real estate finance and leveraged finance.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTucker\u0026nbsp;holds a Bachelor of Arts in English from Colgate University, where he graduated\u0026nbsp;\u003cem\u003emagna cum laude\u003c/em\u003e\u0026nbsp;with high honors in English Literature. He earned his J.D. from Wake Forest University School of Law and a Masters of Laws in Banking Law and Financial Regulation from the London School of Economics and Political Science.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Tucker\u0026nbsp;served as clerk to the Honorable Denise K. Vowell and the Honorable Christian J. Moran, both of the U.S. Court of Federal Claims Office of Special Masters which adjudicates vaccine injury claims brought under the National Childhood Vaccine Injury Act of 1986.\u003c/p\u003e","matters":["\u003cp\u003eThe sole lender in connection with the recapitalization of a luxury Miami hotel.\u003c/p\u003e","\u003cp\u003eThe administrative agent in connection with the construction and development of mixed-use properties in Florida and California.\u003c/p\u003e","\u003cp\u003eA private wealth lender with respect to loans made to a high-net-worth individuals for the purchase of homes in New York and Montana and the construction of a luxury yacht.\u003c/p\u003e","\u003cp\u003eThe administrative agent in connection with the financing of a rapidly-expanding national restaurant chain.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10808}]},"capability_group_id":1},"created_at":"2025-05-26T04:53:10.000Z","updated_at":"2025-05-26T04:53:10.000Z","searchable_text":"McCarthy{{ FIELD }}The sole lender in connection with the recapitalization of a luxury Miami hotel.{{ FIELD }}The administrative agent in connection with the construction and development of mixed-use properties in Florida and California.{{ FIELD }}A private wealth lender with respect to loans made to a high-net-worth individuals for the purchase of homes in New York and Montana and the construction of a luxury yacht.{{ FIELD }}The administrative agent in connection with the financing of a rapidly-expanding national restaurant chain.{{ FIELD }}Tucker McCarthy is a Partner with King \u0026amp; Spalding's Real Estate and Banking and Institutional Finance practices.  Resident in the Washington, D.C. office, Tucker represents lenders and borrowers in various secured lending transactions, with a focus on commercial real estate finance and leveraged finance.\nTucker holds a Bachelor of Arts in English from Colgate University, where he graduated magna cum laude with high honors in English Literature. He earned his J.D. from Wake Forest University School of Law and a Masters of Laws in Banking Law and Financial Regulation from the London School of Economics and Political Science.\nPrior to joining King \u0026amp; Spalding, Tucker served as clerk to the Honorable Denise K. Vowell and the Honorable Christian J. Moran, both of the U.S. Court of Federal Claims Office of Special Masters which adjudicates vaccine injury claims brought under the National Childhood Vaccine Injury Act of 1986. Partner District of Columbia North Carolina New York Law Clerk, Special Masters Denise K. Vowell and Christian J. Moran, U.S. Court of Federal Claims The sole lender in connection with the recapitalization of a luxury Miami hotel. The administrative agent in connection with the construction and development of mixed-use properties in Florida and California. A private wealth lender with respect to loans made to a high-net-worth individuals for the purchase of homes in New York and Montana and the construction of a luxury yacht. The administrative agent in connection with the financing of a rapidly-expanding national restaurant chain.","searchable_name":"Tucker W. McCarthy","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":426421,"version":1,"owner_type":"Person","owner_id":3442,"payload":{"bio":"\u003cp\u003eWilliam McClintock is a partner in King \u0026amp; Spalding\u0026rsquo;s Washington, D.C. office and a member of the firm\u0026rsquo;s Special Matters and Government Investigations practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWilliam focuses his practice on government investigations, internal investigations, voluntary self-disclosures, and white collar criminal litigation. William advises clients on a range of white collar matters, including: the False Claims Act, the Anti-Kickback Statute, the Food Drug \u0026amp; Cosmetic Act, the Foreign Corrupt Practices Act, and whistleblower cases.\u003c/p\u003e\n\u003cp\u003eWilliam has experience representing companies and individuals in investigations conducted by federal and state authorities, including the Department of Justice, multiple United States Attorney\u0026rsquo;s offices, the Department of Health and Human Services Office of Inspector General, the Food and Drug Administration, the Environmental Protection Agency, the Securities and Exchange Commission, the Office of Comptroller of the Currency,\u0026nbsp;the Federal Election Commission,\u0026nbsp;and multiple investigative committees of the United States Congress.\u003c/p\u003e\n\u003cp\u003eWilliam previously served as a law clerk to the Honorable Richard J. Leon of the United States District Court for the District of Columbia.\u0026nbsp; William graduated summa cum laude from Notre Dame Law School, where he served as the Managing Articles Editor of the Notre Dame Law Review.\u003c/p\u003e","slug":"william-mcclintock","email":"wmcclintock@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":4,"guid":"4.aofs","index":0,"source":"aofs"},{"id":6,"guid":"6.aofs","index":1,"source":"aofs"},{"id":780,"guid":"780.smart_tags","index":2,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":973,"guid":"973.smart_tags","index":7,"source":"smartTags"},{"id":984,"guid":"984.smart_tags","index":8,"source":"smartTags"},{"id":113,"guid":"113.capabilities","index":9,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"McClintock","nick_name":"William","clerkships":[{"name":"Law Clerk, Hon. Richard J. Leon, U.S. District Court for the District of Columbia","years_held":"2016 - 2017"}],"first_name":"William","title_rank":9999,"updated_by":176,"law_schools":[{"id":2278,"meta":{"degree":"J.D.","honors":"summa cum laude","is_law_school":1,"graduation_date":"2014-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"S.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWilliam McClintock is a partner in King \u0026amp; Spalding\u0026rsquo;s Washington, D.C. office and a member of the firm\u0026rsquo;s Special Matters and Government Investigations practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWilliam focuses his practice on government investigations, internal investigations, voluntary self-disclosures, and white collar criminal litigation. William advises clients on a range of white collar matters, including: the False Claims Act, the Anti-Kickback Statute, the Food Drug \u0026amp; Cosmetic Act, the Foreign Corrupt Practices Act, and whistleblower cases.\u003c/p\u003e\n\u003cp\u003eWilliam has experience representing companies and individuals in investigations conducted by federal and state authorities, including the Department of Justice, multiple United States Attorney\u0026rsquo;s offices, the Department of Health and Human Services Office of Inspector General, the Food and Drug Administration, the Environmental Protection Agency, the Securities and Exchange Commission, the Office of Comptroller of the Currency,\u0026nbsp;the Federal Election Commission,\u0026nbsp;and multiple investigative committees of the United States Congress.\u003c/p\u003e\n\u003cp\u003eWilliam previously served as a law clerk to the Honorable Richard J. Leon of the United States District Court for the District of Columbia.\u0026nbsp; William graduated summa cum laude from Notre Dame Law School, where he served as the Managing Articles Editor of the Notre Dame Law Review.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6011}]},"capability_group_id":2},"created_at":"2025-05-26T04:52:49.000Z","updated_at":"2025-05-26T04:52:49.000Z","searchable_text":"McClintock{{ FIELD }}William McClintock is a partner in King \u0026amp; Spalding’s Washington, D.C. office and a member of the firm’s Special Matters and Government Investigations practice.\nWilliam focuses his practice on government investigations, internal investigations, voluntary self-disclosures, and white collar criminal litigation. William advises clients on a range of white collar matters, including: the False Claims Act, the Anti-Kickback Statute, the Food Drug \u0026amp; Cosmetic Act, the Foreign Corrupt Practices Act, and whistleblower cases.\nWilliam has experience representing companies and individuals in investigations conducted by federal and state authorities, including the Department of Justice, multiple United States Attorney’s offices, the Department of Health and Human Services Office of Inspector General, the Food and Drug Administration, the Environmental Protection Agency, the Securities and Exchange Commission, the Office of Comptroller of the Currency, the Federal Election Commission, and multiple investigative committees of the United States Congress.\nWilliam previously served as a law clerk to the Honorable Richard J. Leon of the United States District Court for the District of Columbia.  William graduated summa cum laude from Notre Dame Law School, where he served as the Managing Articles Editor of the Notre Dame Law Review. Partner Furman University  University of Notre Dame Notre Dame Law School District of Columbia Georgia Law Clerk, Hon. Richard J. Leon, U.S. District Court for the District of Columbia","searchable_name":"William S. McClintock","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":176,"capability_group_featured":null,"home_page_featured":null},{"id":437140,"version":1,"owner_type":"Person","owner_id":7216,"payload":{"bio":"\u003cp\u003eMatthew D. McGill is a leader in arbitral award and judgment enforcement and an accomplished appellate advocate who handles civil litigation appeals in the Supreme Court of the United States and courts of appeals around the country. Over the last 20+ years, Matt has argued five cases before the Supreme Court of the United States and participated in many more, including several high-profile triumphs over foreign sovereigns.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eA three-time \u0026ldquo;Litigator of the Week\u0026rdquo; \u003cem\u003e(The AmLaw Litigation Daily\u003c/em\u003e), Matt is consistently ranked by \u003cem\u003eChambers USA in Nationwide Appellate Law\u003c/em\u003e (2007-2025) and has been recognized by \u003cem\u003eThe National Law Journal\u003c/em\u003e as a 2020 \u0026ldquo;Litigation Trailblazer\u0026rdquo; for his pioneering work enforcing judgments against foreign sovereigns. Most recently, Matthew has been named to \u003cem\u003eLawdragon\u003c/em\u003e\u0026rsquo;s \u0026ldquo;500 Leading Litigators in America\u0026rdquo; guide (2024-2025) and was listed as a \u0026ldquo;Leading Global Litigator\u0026rdquo; for 2025.\u003c/p\u003e\n\u003cp\u003eAmong his many achievements, in 2020, Matthew successfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania. Previously, he successfully resolved NML Capital\u0026rsquo;s multi-billion dollar claims against the Republic of Argentina after what the \u003cem\u003eFinancial Times \u003c/em\u003ecalled \u0026ldquo;the trial of the century in sovereign debt restructuring.\u0026rdquo; His current case load includes public enforcement matters against the governments of Argentina, India, Iran, Spain, and Venezuela.\u003c/p\u003e\n\u003cp\u003eIn addition to his arbitral award enforcement and appellate practice, Matthew is highly regarded for his work at the intersection of sport and gaming. He is featured in the 2024 edition of \u003cem\u003eThe Best Lawyers in America\u003c/em\u003e for Gaming Law and, for his work toward legalizing sports wagering and confining the Wire Act to its intended scope, Matthew has been recognized by \u003cem\u003eLaw360\u003c/em\u003e as a 2019 Sports Law \u0026ldquo;MVP\u0026rdquo; and \u0026ldquo;2020 Sports \u0026amp; Entertainment Trailblazer\u0026rdquo; by The \u003cem\u003eNational Law Journal\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003ePrior entering private practice, Matthew served as a Bristow Fellow in the Office of the Solicitor General at the U.S. Department of Justice. He clerked for the Hon. Joseph M. McLaughlin of the U.S. Court of Appeals for the Second Circuit and the Hon. John G. Roberts, Jr. of the U.S. Court of Appeals for the D.C. Circuit.\u003c/p\u003e","slug":"matthew-mcgill","email":"matthew.mcgill@kslaw.com ","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003e\u003cu\u003eInternational Disputes\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eSuccessfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved NML Capital\u0026rsquo;s multi-billion dollar claims against the Republic of Argentina after what the\u0026nbsp;\u003cem\u003eFinancial Times\u003c/em\u003e\u0026nbsp;called \u0026ldquo;the trial of the century in sovereign debt restructuring.\u003c/p\u003e","\u003cp\u003eObtained $1 billion judgment against the Islamic Republic of Iran for victims of the 2000 bombing of the U.S.S. Cole.\u003c/p\u003e","\u003cp\u003eLeading U.S. enforcement against the Kingdom of Spain of several arbitral awards redressing violations of the Energy Charter Treaty.\u003c/p\u003e","\u003cp\u003eLeading global enforcement of arbitral awards against the Government of India and the Republic of Argentina.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cu\u003eSupreme Court\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003e\u003cem\u003eCC/Devas v. Antrix Corp.\u003c/em\u003e (2025) \u0026ndash; Arguing this case before the Supreme Court, Matt persuaded the Court to reject a lower court ruling that had found no jurisdiction to hear an enforcement action against one of India\u0026rsquo;s state-owed entities.\u0026nbsp; Matt\u0026rsquo;s 9-0 victory safeguarded the ability of arbitral award holders to bring enforcement actions in the United States against foreign sovereigns and their state-owned entities. \u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cem\u003eOpati v. Republic of Sudan\u003c/em\u003e\u0026nbsp;(2020) \u0026ndash; Matt successfully argued before the Supreme Court on behalf of victims of the 1998 bombings of the U.S. Embassies in Kenya and Tanzania and secured a ruling that \u0026ldquo;unanimously reinstated as much as $4.3 billion in punitive damages awarded against Sudan\u0026rdquo; (\u003cem\u003eNew York Times\u003c/em\u003e) setting the stage for the resolution of the Embassy bombing claims and the United States\u0026rsquo; delisting of Sudan as a state-sponsor of terrorism.\u003c/p\u003e","\u003cp\u003e\u003cem\u003ePuerto Rico v. Franklin California Tax-Free Trust\u003c/em\u003e\u0026nbsp;(2016) \u0026ndash; Arguing before the Supreme Court on behalf of creditors that found themselves on the leading edge of Puerto Rico\u0026rsquo;s debt crisis, Matthew successfully defended an injunction invalidating Puerto Rico\u0026rsquo;s emergency municipal bankruptcy legislation. The ruling protected bondholders against the \u0026ldquo;chance that the territory could write its own bankruptcy plan\u0026rdquo; (\u003cem\u003eWall Street Journal\u003c/em\u003e) and ensured that Congress would retain control over Puerto Rico\u0026rsquo;s fiscal rescue.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eBank Markazi v. Peterson\u003c/em\u003e\u0026nbsp;(2016) \u0026ndash; In this important separation-of-powers case, Matthew represented victims of the 1983 Beirut Marine Corps Barracks Bombing who hold judgments against Iran. Ruling in favor of the Beirut Marines, the Supreme Court rejected arguments from Iran\u0026rsquo;s central bank that Congress had impermissibly invaded the province of the Judicial Branch by authorizing victims of terrorism to seize certain central bank assets. The ruling allowed nearly $2 billion to be distributed to Iran\u0026rsquo;s victims.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eArgentina v. NML Capital, Ltd.\u003c/em\u003e\u0026nbsp;(2014) \u0026ndash; The Supreme Court\u0026rsquo;s decision in this case confirmed the availability of broad discovery to enforce judgments against foreign sovereigns, empowering creditors to seek information concerning the debtor nation\u0026rsquo;s assets anywhere in the world.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cu\u003eSports and Gaming\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eLed the effort of the Governor of New Jersey to legalize sports wagering in the State, culminating in the Supreme Court\u0026rsquo;s \u0026ldquo;historic decision\u0026rdquo; (\u003cem\u003eSports Illustrated\u003c/em\u003e) in \u003cem\u003eMurphy v. NCAA\u003c/em\u003e that struck down the federal law that had prohibited states other than Nevada from legalizing sports betting. By establishing that the federal government has no power to \u0026ldquo;dictate what a state legislature may and may not do,\u0026rdquo; this \u0026ldquo;landmark ruling\u0026rdquo; (\u003cem\u003eUSA Today\u003c/em\u003e) safeguards the power of States to govern themselves and cleared the path for States across the country to legalize sports wagering.\u003c/p\u003e","\u003cp\u003eRepresented the technology provider for the internet-based operations of the New Hampshire Lottery, and secured a judgment that the Wire Act covered only sports betting, and successfully defended that judgment on appeal. The ruling safeguarded \u0026ldquo;the entire online gambling industry as well as multi-state lotteries such as Powerball\u0026rdquo; (\u003cem\u003eAm Law Litigation Daily\u003c/em\u003e) from an arbitrary change in government policy.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":14,"guid":"14.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":38,"guid":"38.capabilities","index":3,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":4,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":7,"source":"capabilities"},{"id":131,"guid":"131.capabilities","index":8,"source":"capabilities"},{"id":1166,"guid":"1166.smart_tags","index":9,"source":"smartTags"},{"id":1,"guid":"1.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"McGill","nick_name":"Matt","clerkships":[{"name":"Law Clerk, Hon. John G. Roberts, Jr., U.S. Court of Appeals for the D.C. Circuit","years_held":"2003 - 2004"},{"name":"Law Clerk, Hon. Joseph M. McLaughlin, U.S. Court of Appeals for the Second Circuit","years_held":"2000 - 2002"}],"first_name":"Matthew","title_rank":9999,"updated_by":202,"law_schools":[{"id":1904,"meta":{"degree":"J.D.","honors":"Order of the Coif","is_law_school":"1","graduation_date":"2000-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"D.","name_suffix":"","recognitions":[{"title":"Ranked for Nationwide Appellate Law","detail":"Chambers \u0026 Partners, 2025"},{"title":"500 Leading Litigators in America","detail":"Lawdragon, 2025"},{"title":"Recognized for Work in Gaming Law","detail":"Best Lawyers in America, 2024"},{"title":"Litigation and Sports Trailblazer","detail":"The National Law Journal, 2020"},{"title":"Sports Law MVP","detail":"Law360, 2019"}],"linked_in_url":"https://www.linkedin.com/in/matthew-mcgill-7737564/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMatthew D. McGill is a leader in arbitral award and judgment enforcement and an accomplished appellate advocate who handles civil litigation appeals in the Supreme Court of the United States and courts of appeals around the country. Over the last 20+ years, Matt has argued five cases before the Supreme Court of the United States and participated in many more, including several high-profile triumphs over foreign sovereigns.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eA three-time \u0026ldquo;Litigator of the Week\u0026rdquo; \u003cem\u003e(The AmLaw Litigation Daily\u003c/em\u003e), Matt is consistently ranked by \u003cem\u003eChambers USA in Nationwide Appellate Law\u003c/em\u003e (2007-2025) and has been recognized by \u003cem\u003eThe National Law Journal\u003c/em\u003e as a 2020 \u0026ldquo;Litigation Trailblazer\u0026rdquo; for his pioneering work enforcing judgments against foreign sovereigns. Most recently, Matthew has been named to \u003cem\u003eLawdragon\u003c/em\u003e\u0026rsquo;s \u0026ldquo;500 Leading Litigators in America\u0026rdquo; guide (2024-2025) and was listed as a \u0026ldquo;Leading Global Litigator\u0026rdquo; for 2025.\u003c/p\u003e\n\u003cp\u003eAmong his many achievements, in 2020, Matthew successfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania. Previously, he successfully resolved NML Capital\u0026rsquo;s multi-billion dollar claims against the Republic of Argentina after what the \u003cem\u003eFinancial Times \u003c/em\u003ecalled \u0026ldquo;the trial of the century in sovereign debt restructuring.\u0026rdquo; His current case load includes public enforcement matters against the governments of Argentina, India, Iran, Spain, and Venezuela.\u003c/p\u003e\n\u003cp\u003eIn addition to his arbitral award enforcement and appellate practice, Matthew is highly regarded for his work at the intersection of sport and gaming. He is featured in the 2024 edition of \u003cem\u003eThe Best Lawyers in America\u003c/em\u003e for Gaming Law and, for his work toward legalizing sports wagering and confining the Wire Act to its intended scope, Matthew has been recognized by \u003cem\u003eLaw360\u003c/em\u003e as a 2019 Sports Law \u0026ldquo;MVP\u0026rdquo; and \u0026ldquo;2020 Sports \u0026amp; Entertainment Trailblazer\u0026rdquo; by The \u003cem\u003eNational Law Journal\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003ePrior entering private practice, Matthew served as a Bristow Fellow in the Office of the Solicitor General at the U.S. Department of Justice. He clerked for the Hon. Joseph M. McLaughlin of the U.S. Court of Appeals for the Second Circuit and the Hon. John G. Roberts, Jr. of the U.S. Court of Appeals for the D.C. Circuit.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003e\u003cu\u003eInternational Disputes\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eSuccessfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved NML Capital\u0026rsquo;s multi-billion dollar claims against the Republic of Argentina after what the\u0026nbsp;\u003cem\u003eFinancial Times\u003c/em\u003e\u0026nbsp;called \u0026ldquo;the trial of the century in sovereign debt restructuring.\u003c/p\u003e","\u003cp\u003eObtained $1 billion judgment against the Islamic Republic of Iran for victims of the 2000 bombing of the U.S.S. Cole.\u003c/p\u003e","\u003cp\u003eLeading U.S. enforcement against the Kingdom of Spain of several arbitral awards redressing violations of the Energy Charter Treaty.\u003c/p\u003e","\u003cp\u003eLeading global enforcement of arbitral awards against the Government of India and the Republic of Argentina.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cu\u003eSupreme Court\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003e\u003cem\u003eCC/Devas v. Antrix Corp.\u003c/em\u003e (2025) \u0026ndash; Arguing this case before the Supreme Court, Matt persuaded the Court to reject a lower court ruling that had found no jurisdiction to hear an enforcement action against one of India\u0026rsquo;s state-owed entities.\u0026nbsp; Matt\u0026rsquo;s 9-0 victory safeguarded the ability of arbitral award holders to bring enforcement actions in the United States against foreign sovereigns and their state-owned entities. \u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cem\u003eOpati v. Republic of Sudan\u003c/em\u003e\u0026nbsp;(2020) \u0026ndash; Matt successfully argued before the Supreme Court on behalf of victims of the 1998 bombings of the U.S. Embassies in Kenya and Tanzania and secured a ruling that \u0026ldquo;unanimously reinstated as much as $4.3 billion in punitive damages awarded against Sudan\u0026rdquo; (\u003cem\u003eNew York Times\u003c/em\u003e) setting the stage for the resolution of the Embassy bombing claims and the United States\u0026rsquo; delisting of Sudan as a state-sponsor of terrorism.\u003c/p\u003e","\u003cp\u003e\u003cem\u003ePuerto Rico v. Franklin California Tax-Free Trust\u003c/em\u003e\u0026nbsp;(2016) \u0026ndash; Arguing before the Supreme Court on behalf of creditors that found themselves on the leading edge of Puerto Rico\u0026rsquo;s debt crisis, Matthew successfully defended an injunction invalidating Puerto Rico\u0026rsquo;s emergency municipal bankruptcy legislation. The ruling protected bondholders against the \u0026ldquo;chance that the territory could write its own bankruptcy plan\u0026rdquo; (\u003cem\u003eWall Street Journal\u003c/em\u003e) and ensured that Congress would retain control over Puerto Rico\u0026rsquo;s fiscal rescue.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eBank Markazi v. Peterson\u003c/em\u003e\u0026nbsp;(2016) \u0026ndash; In this important separation-of-powers case, Matthew represented victims of the 1983 Beirut Marine Corps Barracks Bombing who hold judgments against Iran. Ruling in favor of the Beirut Marines, the Supreme Court rejected arguments from Iran\u0026rsquo;s central bank that Congress had impermissibly invaded the province of the Judicial Branch by authorizing victims of terrorism to seize certain central bank assets. The ruling allowed nearly $2 billion to be distributed to Iran\u0026rsquo;s victims.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eArgentina v. NML Capital, Ltd.\u003c/em\u003e\u0026nbsp;(2014) \u0026ndash; The Supreme Court\u0026rsquo;s decision in this case confirmed the availability of broad discovery to enforce judgments against foreign sovereigns, empowering creditors to seek information concerning the debtor nation\u0026rsquo;s assets anywhere in the world.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cu\u003eSports and Gaming\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eLed the effort of the Governor of New Jersey to legalize sports wagering in the State, culminating in the Supreme Court\u0026rsquo;s \u0026ldquo;historic decision\u0026rdquo; (\u003cem\u003eSports Illustrated\u003c/em\u003e) in \u003cem\u003eMurphy v. NCAA\u003c/em\u003e that struck down the federal law that had prohibited states other than Nevada from legalizing sports betting. By establishing that the federal government has no power to \u0026ldquo;dictate what a state legislature may and may not do,\u0026rdquo; this \u0026ldquo;landmark ruling\u0026rdquo; (\u003cem\u003eUSA Today\u003c/em\u003e) safeguards the power of States to govern themselves and cleared the path for States across the country to legalize sports wagering.\u003c/p\u003e","\u003cp\u003eRepresented the technology provider for the internet-based operations of the New Hampshire Lottery, and secured a judgment that the Wire Act covered only sports betting, and successfully defended that judgment on appeal. The ruling safeguarded \u0026ldquo;the entire online gambling industry as well as multi-state lotteries such as Powerball\u0026rdquo; (\u003cem\u003eAm Law Litigation Daily\u003c/em\u003e) from an arbitrary change in government policy.\u003c/p\u003e"],"recognitions":[{"title":"Ranked for Nationwide Appellate Law","detail":"Chambers \u0026 Partners, 2025"},{"title":"500 Leading Litigators in America","detail":"Lawdragon, 2025"},{"title":"Recognized for Work in Gaming Law","detail":"Best Lawyers in America, 2024"},{"title":"Litigation and Sports Trailblazer","detail":"The National Law Journal, 2020"},{"title":"Sports Law MVP","detail":"Law360, 2019"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12931}]},"capability_group_id":3},"created_at":"2025-09-11T18:32:36.000Z","updated_at":"2025-09-11T18:32:36.000Z","searchable_text":"McGill{{ FIELD }}{:title=\u0026gt;\"Ranked for Nationwide Appellate Law\", :detail=\u0026gt;\"Chambers \u0026amp; Partners, 2025\"}{{ FIELD }}{:title=\u0026gt;\"500 Leading Litigators in America\", :detail=\u0026gt;\"Lawdragon, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for Work in Gaming Law\", :detail=\u0026gt;\"Best Lawyers in America, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Litigation and Sports Trailblazer\", :detail=\u0026gt;\"The National Law Journal, 2020\"}{{ FIELD }}{:title=\u0026gt;\"Sports Law MVP\", :detail=\u0026gt;\"Law360, 2019\"}{{ FIELD }}International Disputes{{ FIELD }}Successfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania.{{ FIELD }}Successfully resolved NML Capital’s multi-billion dollar claims against the Republic of Argentina after what the Financial Times called “the trial of the century in sovereign debt restructuring.{{ FIELD }}Obtained $1 billion judgment against the Islamic Republic of Iran for victims of the 2000 bombing of the U.S.S. Cole.{{ FIELD }}Leading U.S. enforcement against the Kingdom of Spain of several arbitral awards redressing violations of the Energy Charter Treaty.{{ FIELD }}Leading global enforcement of arbitral awards against the Government of India and the Republic of Argentina.{{ FIELD }}Supreme Court{{ FIELD }}CC/Devas v. Antrix Corp. (2025) – Arguing this case before the Supreme Court, Matt persuaded the Court to reject a lower court ruling that had found no jurisdiction to hear an enforcement action against one of India’s state-owed entities.  Matt’s 9-0 victory safeguarded the ability of arbitral award holders to bring enforcement actions in the United States against foreign sovereigns and their state-owned entities.  {{ FIELD }}Opati v. Republic of Sudan (2020) – Matt successfully argued before the Supreme Court on behalf of victims of the 1998 bombings of the U.S. Embassies in Kenya and Tanzania and secured a ruling that “unanimously reinstated as much as $4.3 billion in punitive damages awarded against Sudan” (New York Times) setting the stage for the resolution of the Embassy bombing claims and the United States’ delisting of Sudan as a state-sponsor of terrorism.{{ FIELD }}Puerto Rico v. Franklin California Tax-Free Trust (2016) – Arguing before the Supreme Court on behalf of creditors that found themselves on the leading edge of Puerto Rico’s debt crisis, Matthew successfully defended an injunction invalidating Puerto Rico’s emergency municipal bankruptcy legislation. The ruling protected bondholders against the “chance that the territory could write its own bankruptcy plan” (Wall Street Journal) and ensured that Congress would retain control over Puerto Rico’s fiscal rescue.{{ FIELD }}Bank Markazi v. Peterson (2016) – In this important separation-of-powers case, Matthew represented victims of the 1983 Beirut Marine Corps Barracks Bombing who hold judgments against Iran. Ruling in favor of the Beirut Marines, the Supreme Court rejected arguments from Iran’s central bank that Congress had impermissibly invaded the province of the Judicial Branch by authorizing victims of terrorism to seize certain central bank assets. The ruling allowed nearly $2 billion to be distributed to Iran’s victims.{{ FIELD }}Argentina v. NML Capital, Ltd. (2014) – The Supreme Court’s decision in this case confirmed the availability of broad discovery to enforce judgments against foreign sovereigns, empowering creditors to seek information concerning the debtor nation’s assets anywhere in the world.{{ FIELD }}Sports and Gaming{{ FIELD }}Led the effort of the Governor of New Jersey to legalize sports wagering in the State, culminating in the Supreme Court’s “historic decision” (Sports Illustrated) in Murphy v. NCAA that struck down the federal law that had prohibited states other than Nevada from legalizing sports betting. By establishing that the federal government has no power to “dictate what a state legislature may and may not do,” this “landmark ruling” (USA Today) safeguards the power of States to govern themselves and cleared the path for States across the country to legalize sports wagering.{{ FIELD }}Represented the technology provider for the internet-based operations of the New Hampshire Lottery, and secured a judgment that the Wire Act covered only sports betting, and successfully defended that judgment on appeal. The ruling safeguarded “the entire online gambling industry as well as multi-state lotteries such as Powerball” (Am Law Litigation Daily) from an arbitrary change in government policy.{{ FIELD }}Matthew D. McGill is a leader in arbitral award and judgment enforcement and an accomplished appellate advocate who handles civil litigation appeals in the Supreme Court of the United States and courts of appeals around the country. Over the last 20+ years, Matt has argued five cases before the Supreme Court of the United States and participated in many more, including several high-profile triumphs over foreign sovereigns.\nA three-time “Litigator of the Week” (The AmLaw Litigation Daily), Matt is consistently ranked by Chambers USA in Nationwide Appellate Law (2007-2025) and has been recognized by The National Law Journal as a 2020 “Litigation Trailblazer” for his pioneering work enforcing judgments against foreign sovereigns. Most recently, Matthew has been named to Lawdragon’s “500 Leading Litigators in America” guide (2024-2025) and was listed as a “Leading Global Litigator” for 2025.\nAmong his many achievements, in 2020, Matthew successfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania. Previously, he successfully resolved NML Capital’s multi-billion dollar claims against the Republic of Argentina after what the Financial Times called “the trial of the century in sovereign debt restructuring.” His current case load includes public enforcement matters against the governments of Argentina, India, Iran, Spain, and Venezuela.\nIn addition to his arbitral award enforcement and appellate practice, Matthew is highly regarded for his work at the intersection of sport and gaming. He is featured in the 2024 edition of The Best Lawyers in America for Gaming Law and, for his work toward legalizing sports wagering and confining the Wire Act to its intended scope, Matthew has been recognized by Law360 as a 2019 Sports Law “MVP” and “2020 Sports \u0026amp; Entertainment Trailblazer” by The National Law Journal.\nPrior entering private practice, Matthew served as a Bristow Fellow in the Office of the Solicitor General at the U.S. Department of Justice. He clerked for the Hon. Joseph M. McLaughlin of the U.S. Court of Appeals for the Second Circuit and the Hon. John G. Roberts, Jr. of the U.S. Court of Appeals for the D.C. Circuit. Partner Ranked for Nationwide Appellate Law Chambers \u0026amp; Partners, 2025 500 Leading Litigators in America Lawdragon, 2025 Recognized for Work in Gaming Law Best Lawyers in America, 2024 Litigation and Sports Trailblazer The National Law Journal, 2020 Sports Law MVP Law360, 2019 Dartmouth College  Stanford University Stanford Law School District of Columbia New York Law Clerk, Hon. John G. Roberts, Jr., U.S. Court of Appeals for the D.C. Circuit Law Clerk, Hon. Joseph M. McLaughlin, U.S. Court of Appeals for the Second Circuit International Disputes Successfully negotiated a $335 million resolution of terrorism claims against the Republic of Sudan arising from the 1998 bombings of the U.S. Embassies in Kenya and Tanzania. Successfully resolved NML Capital’s multi-billion dollar claims against the Republic of Argentina after what the Financial Times called “the trial of the century in sovereign debt restructuring. Obtained $1 billion judgment against the Islamic Republic of Iran for victims of the 2000 bombing of the U.S.S. Cole. Leading U.S. enforcement against the Kingdom of Spain of several arbitral awards redressing violations of the Energy Charter Treaty. Leading global enforcement of arbitral awards against the Government of India and the Republic of Argentina. Supreme Court CC/Devas v. Antrix Corp. (2025) – Arguing this case before the Supreme Court, Matt persuaded the Court to reject a lower court ruling that had found no jurisdiction to hear an enforcement action against one of India’s state-owed entities.  Matt’s 9-0 victory safeguarded the ability of arbitral award holders to bring enforcement actions in the United States against foreign sovereigns and their state-owned entities.   Opati v. Republic of Sudan (2020) – Matt successfully argued before the Supreme Court on behalf of victims of the 1998 bombings of the U.S. Embassies in Kenya and Tanzania and secured a ruling that “unanimously reinstated as much as $4.3 billion in punitive damages awarded against Sudan” (New York Times) setting the stage for the resolution of the Embassy bombing claims and the United States’ delisting of Sudan as a state-sponsor of terrorism. Puerto Rico v. Franklin California Tax-Free Trust (2016) – Arguing before the Supreme Court on behalf of creditors that found themselves on the leading edge of Puerto Rico’s debt crisis, Matthew successfully defended an injunction invalidating Puerto Rico’s emergency municipal bankruptcy legislation. The ruling protected bondholders against the “chance that the territory could write its own bankruptcy plan” (Wall Street Journal) and ensured that Congress would retain control over Puerto Rico’s fiscal rescue. Bank Markazi v. Peterson (2016) – In this important separation-of-powers case, Matthew represented victims of the 1983 Beirut Marine Corps Barracks Bombing who hold judgments against Iran. Ruling in favor of the Beirut Marines, the Supreme Court rejected arguments from Iran’s central bank that Congress had impermissibly invaded the province of the Judicial Branch by authorizing victims of terrorism to seize certain central bank assets. The ruling allowed nearly $2 billion to be distributed to Iran’s victims. Argentina v. NML Capital, Ltd. (2014) – The Supreme Court’s decision in this case confirmed the availability of broad discovery to enforce judgments against foreign sovereigns, empowering creditors to seek information concerning the debtor nation’s assets anywhere in the world. Sports and Gaming Led the effort of the Governor of New Jersey to legalize sports wagering in the State, culminating in the Supreme Court’s “historic decision” (Sports Illustrated) in Murphy v. NCAA that struck down the federal law that had prohibited states other than Nevada from legalizing sports betting. By establishing that the federal government has no power to “dictate what a state legislature may and may not do,” this “landmark ruling” (USA Today) safeguards the power of States to govern themselves and cleared the path for States across the country to legalize sports wagering. Represented the technology provider for the internet-based operations of the New Hampshire Lottery, and secured a judgment that the Wire Act covered only sports betting, and successfully defended that judgment on appeal. The ruling safeguarded “the entire online gambling industry as well as multi-state lotteries such as Powerball” (Am Law Litigation Daily) from an arbitrary change in government policy.","searchable_name":"Matthew D. McGill (Matt)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444450,"version":1,"owner_type":"Person","owner_id":2728,"payload":{"bio":"\u003cp\u003eAmelia Medina represents\u0026nbsp;corporations, nonprofit organizations,\u0026nbsp;and board committees in major\u0026nbsp;investigations and disputes with government authorities.\u0026nbsp; A\u0026nbsp;partner in\u0026nbsp;King \u0026amp; Spalding's \u003cem\u003eChambers\u003c/em\u003e Band 1-ranked practice in Corporate Crime \u0026amp; Investigations, Amelia also specializes in litigation\u0026nbsp;involving\u0026nbsp;civil fraud,\u0026nbsp;national security, the\u0026nbsp;False Claims Act and \u003cem\u003equi tam \u003c/em\u003ewhistleblowers. Executives in regulated industries -- especially\u0026nbsp;life sciences, healthcare,\u0026nbsp;defense, technology, financial services, artificial intelligence, and government contracting --\u0026nbsp;turn to Amelia for her current insights about\u0026nbsp;domestic and\u0026nbsp;international law enforcement trends.\u003c/p\u003e\n\u003cp\u003ePrior to rejoining King \u0026amp; Spalding, Amelia served as Deputy Chief of Staff to the Director of the FBI, and as Senior Counsel to the U.S. Deputy Attorney General (DAG) at the Department of Justice.\u0026nbsp;\u0026nbsp;She also served as a federal criminal prosecutor\u0026nbsp;in the Financial Crimes \u0026amp; Public Corruption Unit of the U.S. Attorney\u0026rsquo;s Office for the Eastern District of Virginia.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAt the FBI, Amelia advised the Director and FBI leadership on all aspects of\u0026nbsp;investigations regarding complex financial fraud, healthcare fraud, procurement fraud and collusion,\u0026nbsp;trade sanctions and export controls,\u0026nbsp;cyber and security-related critical incidents, official corruption, counterintelligence, and issues before the National Security Council.\u0026nbsp; Amelia also prepared and advised\u0026nbsp;the FBI Director during numerous congressional hearings, including\u0026nbsp;at\u0026nbsp;\u0026ldquo;members only\u0026rdquo; classified briefings to the full U.S. Congress.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAs Senior Counsel in the Office of the Deputy Attorney General from 2017-2018, Amelia managed a department-wide portfolio of corporate enforcement priorities, compliance initiatives, and\u0026nbsp;case-specific issues arising across Main Justice divisions and U.S. Attorneys\u0026rsquo; Offices, as well as multi-agency efforts with SEC, CFTC,\u0026nbsp;DHS, HHS, FDA,\u0026nbsp;and various agency Offices of Inspector General.\u0026nbsp; Amelia served as the first Chair of the Corporate Enforcement \u0026amp; Accountability Working Group, a leadership committee responsible for guiding the DOJ\u0026rsquo;s strategy and policies to combat corporate criminal and civil fraud nationwide. She played an integral part in the development and implementation of the Foreign Corrupt Practices Act Corporate Enforcement Policy and served as the principal staff counselor to the DAG on approvals of corporate compliance monitorships.\u003c/p\u003e\n\u003cp\u003eIn private practice, Amelia is experienced in steering responses to oversight requests by\u0026nbsp;congressional committees in the U.S. House and Senate. She also\u0026nbsp;prepares business leaders to give testimony at televised hearings before federal\u0026nbsp;and state legislative bodies.\u003c/p\u003e\n\u003cp\u003eAmelia\u0026nbsp;is a member of the invitation-only Edward Bennett Williams Inn of Court for\u0026nbsp;white collar practitioners in Washington, D.C. She serves on the boards of the Atlanta Police Foundation and The Goizueta Foundation.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmelia\u0026nbsp;graduated Phi Beta Kappa from Princeton University, with a degree from the School of Public \u0026amp; International Affairs.\u0026nbsp; She holds a J.D. from Yale Law School and was a member of The Yale Law Journal.\u003c/p\u003e","slug":"amelia-medina","email":"amedina@kslaw.com","phone":"+1 202 900 0822","matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":1,"source":"smartTags"},{"id":110,"guid":"110.capabilities","index":2,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":3,"source":"smartTags"},{"id":20,"guid":"20.capabilities","index":4,"source":"capabilities"},{"id":5,"guid":"5.smart_tags","index":5,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":6,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":7,"source":"capabilities"},{"id":1147,"guid":"1147.smart_tags","index":8,"source":"smartTags"},{"id":81,"guid":"81.capabilities","index":9,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":10,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":11,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":12,"source":"capabilities"},{"id":132,"guid":"132.capabilities","index":13,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":14,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":15,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":16,"source":"smartTags"},{"id":1715,"guid":"1715.smart_tags","index":17,"source":"smartTags"}],"is_active":true,"last_name":"Medina","nick_name":"Amelia","clerkships":[{"name":"Law Clerk, Jose A. Cabranes, U.S. Court of Appeals for the Second Circuit","years_held":"2010-2011"},{"name":"Law Clerk, Michael M. Baylson, U.S. District Court for the Eastern District of Pennsylvania","years_held":"2011-2012"}],"first_name":"Amelia","title_rank":9999,"updated_by":202,"law_schools":[{"id":2605,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2010-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Selected for the White Collar Crime Editorial Advisory Board","detail":"Law360, 2024"},{"title":"Recommended nationally for Government: State Attorneys General","detail":"Legal 500, 2024"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmelia Medina represents\u0026nbsp;corporations, nonprofit organizations,\u0026nbsp;and board committees in major\u0026nbsp;investigations and disputes with government authorities.\u0026nbsp; A\u0026nbsp;partner in\u0026nbsp;King \u0026amp; Spalding's \u003cem\u003eChambers\u003c/em\u003e Band 1-ranked practice in Corporate Crime \u0026amp; Investigations, Amelia also specializes in litigation\u0026nbsp;involving\u0026nbsp;civil fraud,\u0026nbsp;national security, the\u0026nbsp;False Claims Act and \u003cem\u003equi tam \u003c/em\u003ewhistleblowers. Executives in regulated industries -- especially\u0026nbsp;life sciences, healthcare,\u0026nbsp;defense, technology, financial services, artificial intelligence, and government contracting --\u0026nbsp;turn to Amelia for her current insights about\u0026nbsp;domestic and\u0026nbsp;international law enforcement trends.\u003c/p\u003e\n\u003cp\u003ePrior to rejoining King \u0026amp; Spalding, Amelia served as Deputy Chief of Staff to the Director of the FBI, and as Senior Counsel to the U.S. Deputy Attorney General (DAG) at the Department of Justice.\u0026nbsp;\u0026nbsp;She also served as a federal criminal prosecutor\u0026nbsp;in the Financial Crimes \u0026amp; Public Corruption Unit of the U.S. Attorney\u0026rsquo;s Office for the Eastern District of Virginia.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAt the FBI, Amelia advised the Director and FBI leadership on all aspects of\u0026nbsp;investigations regarding complex financial fraud, healthcare fraud, procurement fraud and collusion,\u0026nbsp;trade sanctions and export controls,\u0026nbsp;cyber and security-related critical incidents, official corruption, counterintelligence, and issues before the National Security Council.\u0026nbsp; Amelia also prepared and advised\u0026nbsp;the FBI Director during numerous congressional hearings, including\u0026nbsp;at\u0026nbsp;\u0026ldquo;members only\u0026rdquo; classified briefings to the full U.S. Congress.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAs Senior Counsel in the Office of the Deputy Attorney General from 2017-2018, Amelia managed a department-wide portfolio of corporate enforcement priorities, compliance initiatives, and\u0026nbsp;case-specific issues arising across Main Justice divisions and U.S. Attorneys\u0026rsquo; Offices, as well as multi-agency efforts with SEC, CFTC,\u0026nbsp;DHS, HHS, FDA,\u0026nbsp;and various agency Offices of Inspector General.\u0026nbsp; Amelia served as the first Chair of the Corporate Enforcement \u0026amp; Accountability Working Group, a leadership committee responsible for guiding the DOJ\u0026rsquo;s strategy and policies to combat corporate criminal and civil fraud nationwide. She played an integral part in the development and implementation of the Foreign Corrupt Practices Act Corporate Enforcement Policy and served as the principal staff counselor to the DAG on approvals of corporate compliance monitorships.\u003c/p\u003e\n\u003cp\u003eIn private practice, Amelia is experienced in steering responses to oversight requests by\u0026nbsp;congressional committees in the U.S. House and Senate. She also\u0026nbsp;prepares business leaders to give testimony at televised hearings before federal\u0026nbsp;and state legislative bodies.\u003c/p\u003e\n\u003cp\u003eAmelia\u0026nbsp;is a member of the invitation-only Edward Bennett Williams Inn of Court for\u0026nbsp;white collar practitioners in Washington, D.C. She serves on the boards of the Atlanta Police Foundation and The Goizueta Foundation.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmelia\u0026nbsp;graduated Phi Beta Kappa from Princeton University, with a degree from the School of Public \u0026amp; International Affairs.\u0026nbsp; She holds a J.D. from Yale Law School and was a member of The Yale Law Journal.\u003c/p\u003e","recognitions":[{"title":"Selected for the White Collar Crime Editorial Advisory Board","detail":"Law360, 2024"},{"title":"Recommended nationally for Government: State Attorneys General","detail":"Legal 500, 2024"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12849}]},"capability_group_id":2},"created_at":"2025-12-18T22:13:05.000Z","updated_at":"2025-12-18T22:13:05.000Z","searchable_text":"Medina{{ FIELD }}{:title=\u0026gt;\"Selected for the White Collar Crime Editorial Advisory Board\", :detail=\u0026gt;\"Law360, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended nationally for Government: State Attorneys General\", :detail=\u0026gt;\"Legal 500, 2024\"}{{ FIELD }}Amelia Medina represents corporations, nonprofit organizations, and board committees in major investigations and disputes with government authorities.  A partner in King \u0026amp; Spalding's Chambers Band 1-ranked practice in Corporate Crime \u0026amp; Investigations, Amelia also specializes in litigation involving civil fraud, national security, the False Claims Act and qui tam whistleblowers. Executives in regulated industries -- especially life sciences, healthcare, defense, technology, financial services, artificial intelligence, and government contracting -- turn to Amelia for her current insights about domestic and international law enforcement trends.\nPrior to rejoining King \u0026amp; Spalding, Amelia served as Deputy Chief of Staff to the Director of the FBI, and as Senior Counsel to the U.S. Deputy Attorney General (DAG) at the Department of Justice.  She also served as a federal criminal prosecutor in the Financial Crimes \u0026amp; Public Corruption Unit of the U.S. Attorney’s Office for the Eastern District of Virginia. \nAt the FBI, Amelia advised the Director and FBI leadership on all aspects of investigations regarding complex financial fraud, healthcare fraud, procurement fraud and collusion, trade sanctions and export controls, cyber and security-related critical incidents, official corruption, counterintelligence, and issues before the National Security Council.  Amelia also prepared and advised the FBI Director during numerous congressional hearings, including at “members only” classified briefings to the full U.S. Congress. \nAs Senior Counsel in the Office of the Deputy Attorney General from 2017-2018, Amelia managed a department-wide portfolio of corporate enforcement priorities, compliance initiatives, and case-specific issues arising across Main Justice divisions and U.S. Attorneys’ Offices, as well as multi-agency efforts with SEC, CFTC, DHS, HHS, FDA, and various agency Offices of Inspector General.  Amelia served as the first Chair of the Corporate Enforcement \u0026amp; Accountability Working Group, a leadership committee responsible for guiding the DOJ’s strategy and policies to combat corporate criminal and civil fraud nationwide. She played an integral part in the development and implementation of the Foreign Corrupt Practices Act Corporate Enforcement Policy and served as the principal staff counselor to the DAG on approvals of corporate compliance monitorships.\nIn private practice, Amelia is experienced in steering responses to oversight requests by congressional committees in the U.S. House and Senate. She also prepares business leaders to give testimony at televised hearings before federal and state legislative bodies.\nAmelia is a member of the invitation-only Edward Bennett Williams Inn of Court for white collar practitioners in Washington, D.C. She serves on the boards of the Atlanta Police Foundation and The Goizueta Foundation.  \nAmelia graduated Phi Beta Kappa from Princeton University, with a degree from the School of Public \u0026amp; International Affairs.  She holds a J.D. from Yale Law School and was a member of The Yale Law Journal. Partner Selected for the White Collar Crime Editorial Advisory Board Law360, 2024 Recommended nationally for Government: State Attorneys General Legal 500, 2024 Princeton University  Yale University Yale Law School U.S. Court of Appeals for the Second Circuit U.S. District Court for the Northern District of Georgia District of Columbia Georgia Court of Appeals of Georgia Supreme Court of Georgia Hispanic National Bar Association Board of Directors, The Goizueta Foundation (2019-Present) Board of Directors, Latin American Association (2015-2017) Law Clerk, Jose A. Cabranes, U.S. Court of Appeals for the Second Circuit Law Clerk, Michael M. Baylson, U.S. District Court for the Eastern District of Pennsylvania","searchable_name":"Amelia R. Medina","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445049,"version":1,"owner_type":"Person","owner_id":1416,"payload":{"bio":"\u003cp\u003eBrian Meiners focuses his practice on government antitrust investigations that include criminal and civil matters, merger investigations, and civil litigation. A Partner in our Antitrust practice, Brian represents clients in some of their most complex matters, including global cartel investigations and transactions requiring regulatory approval in multiple jurisdictions. In addition, Brian routinely counsels clients on strategic antitrust issues arising from competitor collaborations, marketing, pricing, distribution practices, and trade association participation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eBrian was named a \u0026ldquo;Future Leader\u0026rdquo; in antitrust law by\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003cem\u003eGlobal Competition Review\u003c/em\u003e\u0026nbsp;in the 2024, 2023, and 2022\u0026nbsp;publications of Competition Law \u0026ndash; Future Leaders.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrian appears regularly before the U.S. Department of Justice Antitrust Division and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe.\u003c/p\u003e\n\u003cp\u003eHe is a member of the Cartel \u0026amp; Criminal Practice Committee, State Enforcement Committee,\u0026nbsp;and the Mergers \u0026amp; Acquisitions Committee of the American Bar Association, Section of Antitrust Law.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Presentations and Publications\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Criminal Antitrust Update: DOJ Announces New Policy Regarding Corporate Compliance Programs,\u0026rdquo; \u003cem\u003eABA Section of Antitrust Law, Cartel and Criminal Practice Committee\u003c/em\u003e (July 2019)\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, Antitrust Law Developments (8th ed.) (April 2017)\u003c/p\u003e\n\u003cp\u003eCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, 2015 Annual Review of Antitrust Law Developments (March 2016)\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Criminal Antitrust Update,\u0026rdquo; \u003cem\u003eABA Section of Antitrust Law, Cartel and Criminal Practice Committee\u003c/em\u003e (November 2014)\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;McWane Dismissal May Impact Future FTC Cases,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (February 2014)\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;Antitrust Bid-Rigging at Natural Gas Auctions,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (April 2012)\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;Key Takeaways From US v. AU Optronics,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (March 2012)\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Dawn Raids, Criminalization of Cartels and Beyond: Are You Ready?\u0026rdquo; King \u0026amp; Spalding and SAI Law \u0026amp; Economics Client Forum (Mexico City, Mexico, November 2011)\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMemberships\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCartel \u0026amp; Criminal Practice Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eState Enforcement Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eMergers \u0026amp; Acquisitions Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eAmerican Health Lawyers Association\u003c/p\u003e","slug":"brian-meiners","email":"bmeiners@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eCartel Investigations and Criminal Litigation Experience:\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eRepresenting a senior executive of an international capacitors manufacturer as lead counsel in connection with a multi-jurisdictional cartel investigation and related civil proceedings.\u003c/p\u003e","\u003cp\u003eRepresenting senior executives of multiple international auto parts manufacturers in connection with a multi-jurisdictional cartel investigation in that industry.\u003c/p\u003e","\u003cp\u003eRepresented the chief executive officer of an international TFT-LCD manufacturer in connection with a multi-jurisdictional cartel investigation and related civil proceedings.\u003c/p\u003e","\u003cp\u003eRepresented a senior sales and marketing executive of an international freight consolidator in connection with a multi-jurisdictional cartel investigation and Foreign Corrupt Practices Act investigation. \u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCivil Antitrust Litigation:\u003cem\u003e\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/em\u003e\u003c/strong\u003eObtained dismissal for a leading national pharmaceutical company in multi-district class action antitrust litigation in In re Generic Pharmaceuticals Pricing Antitrust Litigation.\u003c/p\u003e","\u003cp\u003eObtained dismissal in class action antitrust litigation for the United States Postal Service in\u0026nbsp;\u003cem\u003eTOG, Inc. v. United States Postal Service\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eObtained dismissal for RLI Insurance Company in multi-district class action antitrust litigation in\u0026nbsp;\u003cem\u003eIn re Insurance Brokers Antitrust Litigation\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Trelleborg AB in an international arbitration involving antitrust and fraud claims arising from a stock purchase agreement.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy:\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc. in the offshore oil and gas drilling sector and successfully obtained\u0026nbsp;antitrust clearances in\u0026nbsp;several jurisdictions around the world.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eSuccessfully defended Mirant Corporation in a DOJ Second Request investigation of its merger with RRI Energy, creating one of the largest independent power producers in the United States.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Varel International Energy Services, Inc. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with its acquisition by Sandvik AB.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Weatherford International Ltd. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with the acquisition of its pipeline and specialty services business by Baker Hughes Incorporated.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Edison Chouest Offshore in a DOJ Antitrust Division investigation of its acquisition of Bollinger Shipyards, Inc. in the petroleum offshore services industry.\u003c/p\u003e","\u003cp\u003eRepresented a global energy and petroleum company in an international arbitration involving antitrust and breach of contract claims related to LNG production and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Haddington Ventures, L.L.C. in the acquisition of its gas storage assets.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare/Life Sciences:\u003cem\u003e\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/em\u003e\u003c/strong\u003eSuccessfully defended Piedmont Healthcare, Inc. in a FTC merger investigation of Piedmont\u0026rsquo;s acquisition of a rival hospital system.\u003c/p\u003e","\u003cp\u003eDefended a physician member network in a FTC price-fixing investigation.\u003c/p\u003e","\u003cp\u003eDefended a major pharmaceutical company in a jury trial in United States District Court for the District of Columbia involving antitrust claims arising from exclusive pharmaceutical supply agreements.\u003c/p\u003e","\u003cp\u003eRepresented a leading global branded pharmaceutical company in a DOJ criminal antitrust investigation of a proposed patent settlement with a generic drug company and the use of authorized generics.\u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAntitrust Counseling:\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eAdvises clients on antitrust issues arising from everyday business practices, including compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, refusals to deal, and tying/bundling issues.\u003c/p\u003e","\u003cp\u003eObtained HSR clearances for hundreds of transactions.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePro Bono Litigation Service:\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eServed as co-lead counsel in a federal habeas death penalty proceeding challenging a pro bono client's Virginia capital murder conviction . \u0026nbsp;The proceeding culminated in a multi-day evidentiary hearing in federal district court and received national media coverage due to allegations involving extensive drug dealing by Northern Virginia youths, an alleged murder plot, and the Commonwealth's most experienced prosecutors seeking the death penalty. \u0026nbsp;After federal appellate and district court habeas proceedings, the federal district court issued an opinion vacating our client\u0026rsquo;s conviction and death sentence, finding violations of fundamental constitutional obligations.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":102,"guid":"102.capabilities","index":0,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":4,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":5,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":6,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":7,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":8,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Meiners","nick_name":"Brian","clerkships":[],"first_name":"Brian","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"R.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBrian Meiners focuses his practice on government antitrust investigations that include criminal and civil matters, merger investigations, and civil litigation. A Partner in our Antitrust practice, Brian represents clients in some of their most complex matters, including global cartel investigations and transactions requiring regulatory approval in multiple jurisdictions. In addition, Brian routinely counsels clients on strategic antitrust issues arising from competitor collaborations, marketing, pricing, distribution practices, and trade association participation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eBrian was named a \u0026ldquo;Future Leader\u0026rdquo; in antitrust law by\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003cem\u003eGlobal Competition Review\u003c/em\u003e\u0026nbsp;in the 2024, 2023, and 2022\u0026nbsp;publications of Competition Law \u0026ndash; Future Leaders.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrian appears regularly before the U.S. Department of Justice Antitrust Division and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe.\u003c/p\u003e\n\u003cp\u003eHe is a member of the Cartel \u0026amp; Criminal Practice Committee, State Enforcement Committee,\u0026nbsp;and the Mergers \u0026amp; Acquisitions Committee of the American Bar Association, Section of Antitrust Law.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Presentations and Publications\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Criminal Antitrust Update: DOJ Announces New Policy Regarding Corporate Compliance Programs,\u0026rdquo; \u003cem\u003eABA Section of Antitrust Law, Cartel and Criminal Practice Committee\u003c/em\u003e (July 2019)\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, Antitrust Law Developments (8th ed.) (April 2017)\u003c/p\u003e\n\u003cp\u003eCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, 2015 Annual Review of Antitrust Law Developments (March 2016)\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Criminal Antitrust Update,\u0026rdquo; \u003cem\u003eABA Section of Antitrust Law, Cartel and Criminal Practice Committee\u003c/em\u003e (November 2014)\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;McWane Dismissal May Impact Future FTC Cases,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (February 2014)\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;Antitrust Bid-Rigging at Natural Gas Auctions,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (April 2012)\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;Key Takeaways From US v. AU Optronics,\u0026rdquo; \u003cem\u003eCompetition Law360\u003c/em\u003e (March 2012)\u003c/p\u003e\n\u003cp\u003ePanelist, \u0026ldquo;Dawn Raids, Criminalization of Cartels and Beyond: Are You Ready?\u0026rdquo; King \u0026amp; Spalding and SAI Law \u0026amp; Economics Client Forum (Mexico City, Mexico, November 2011)\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMemberships\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCartel \u0026amp; Criminal Practice Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eState Enforcement Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eMergers \u0026amp; Acquisitions Committee, Antitrust Section, American Bar Association\u003c/p\u003e\n\u003cp\u003eAmerican Health Lawyers Association\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eCartel Investigations and Criminal Litigation Experience:\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eRepresenting a senior executive of an international capacitors manufacturer as lead counsel in connection with a multi-jurisdictional cartel investigation and related civil proceedings.\u003c/p\u003e","\u003cp\u003eRepresenting senior executives of multiple international auto parts manufacturers in connection with a multi-jurisdictional cartel investigation in that industry.\u003c/p\u003e","\u003cp\u003eRepresented the chief executive officer of an international TFT-LCD manufacturer in connection with a multi-jurisdictional cartel investigation and related civil proceedings.\u003c/p\u003e","\u003cp\u003eRepresented a senior sales and marketing executive of an international freight consolidator in connection with a multi-jurisdictional cartel investigation and Foreign Corrupt Practices Act investigation. \u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCivil Antitrust Litigation:\u003cem\u003e\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/em\u003e\u003c/strong\u003eObtained dismissal for a leading national pharmaceutical company in multi-district class action antitrust litigation in In re Generic Pharmaceuticals Pricing Antitrust Litigation.\u003c/p\u003e","\u003cp\u003eObtained dismissal in class action antitrust litigation for the United States Postal Service in\u0026nbsp;\u003cem\u003eTOG, Inc. v. United States Postal Service\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eObtained dismissal for RLI Insurance Company in multi-district class action antitrust litigation in\u0026nbsp;\u003cem\u003eIn re Insurance Brokers Antitrust Litigation\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Trelleborg AB in an international arbitration involving antitrust and fraud claims arising from a stock purchase agreement.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy:\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc. in the offshore oil and gas drilling sector and successfully obtained\u0026nbsp;antitrust clearances in\u0026nbsp;several jurisdictions around the world.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eSuccessfully defended Mirant Corporation in a DOJ Second Request investigation of its merger with RRI Energy, creating one of the largest independent power producers in the United States.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Varel International Energy Services, Inc. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with its acquisition by Sandvik AB.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Weatherford International Ltd. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with the acquisition of its pipeline and specialty services business by Baker Hughes Incorporated.\u003c/p\u003e","\u003cp\u003eSuccessfully defended Edison Chouest Offshore in a DOJ Antitrust Division investigation of its acquisition of Bollinger Shipyards, Inc. in the petroleum offshore services industry.\u003c/p\u003e","\u003cp\u003eRepresented a global energy and petroleum company in an international arbitration involving antitrust and breach of contract claims related to LNG production and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Haddington Ventures, L.L.C. in the acquisition of its gas storage assets.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare/Life Sciences:\u003cem\u003e\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/em\u003e\u003c/strong\u003eSuccessfully defended Piedmont Healthcare, Inc. in a FTC merger investigation of Piedmont\u0026rsquo;s acquisition of a rival hospital system.\u003c/p\u003e","\u003cp\u003eDefended a physician member network in a FTC price-fixing investigation.\u003c/p\u003e","\u003cp\u003eDefended a major pharmaceutical company in a jury trial in United States District Court for the District of Columbia involving antitrust claims arising from exclusive pharmaceutical supply agreements.\u003c/p\u003e","\u003cp\u003eRepresented a leading global branded pharmaceutical company in a DOJ criminal antitrust investigation of a proposed patent settlement with a generic drug company and the use of authorized generics.\u0026nbsp;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAntitrust Counseling:\u0026nbsp;\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eAdvises clients on antitrust issues arising from everyday business practices, including compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, refusals to deal, and tying/bundling issues.\u003c/p\u003e","\u003cp\u003eObtained HSR clearances for hundreds of transactions.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePro Bono Litigation Service:\u003cbr /\u003e\u003cbr /\u003e\u003c/strong\u003eServed as co-lead counsel in a federal habeas death penalty proceeding challenging a pro bono client's Virginia capital murder conviction . \u0026nbsp;The proceeding culminated in a multi-day evidentiary hearing in federal district court and received national media coverage due to allegations involving extensive drug dealing by Northern Virginia youths, an alleged murder plot, and the Commonwealth's most experienced prosecutors seeking the death penalty. \u0026nbsp;After federal appellate and district court habeas proceedings, the federal district court issued an opinion vacating our client\u0026rsquo;s conviction and death sentence, finding violations of fundamental constitutional obligations.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5194}]},"capability_group_id":2},"created_at":"2026-01-14T21:34:16.000Z","updated_at":"2026-01-14T21:34:16.000Z","searchable_text":"Meiners{{ FIELD }}Cartel Investigations and Criminal Litigation Experience: Representing a senior executive of an international capacitors manufacturer as lead counsel in connection with a multi-jurisdictional cartel investigation and related civil proceedings.{{ FIELD }}Representing senior executives of multiple international auto parts manufacturers in connection with a multi-jurisdictional cartel investigation in that industry.{{ FIELD }}Represented the chief executive officer of an international TFT-LCD manufacturer in connection with a multi-jurisdictional cartel investigation and related civil proceedings.{{ FIELD }}Represented a senior sales and marketing executive of an international freight consolidator in connection with a multi-jurisdictional cartel investigation and Foreign Corrupt Practices Act investigation.  {{ FIELD }}Civil Antitrust Litigation: Obtained dismissal for a leading national pharmaceutical company in multi-district class action antitrust litigation in In re Generic Pharmaceuticals Pricing Antitrust Litigation.{{ FIELD }}Obtained dismissal in class action antitrust litigation for the United States Postal Service in TOG, Inc. v. United States Postal Service.{{ FIELD }}Obtained dismissal for RLI Insurance Company in multi-district class action antitrust litigation in In re Insurance Brokers Antitrust Litigation.{{ FIELD }}Successfully defended Trelleborg AB in an international arbitration involving antitrust and fraud claims arising from a stock purchase agreement.{{ FIELD }}Energy: \nRepresented Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc. in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world. {{ FIELD }}Successfully defended Mirant Corporation in a DOJ Second Request investigation of its merger with RRI Energy, creating one of the largest independent power producers in the United States.{{ FIELD }}Successfully defended Varel International Energy Services, Inc. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with its acquisition by Sandvik AB.{{ FIELD }}Successfully defended Weatherford International Ltd. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with the acquisition of its pipeline and specialty services business by Baker Hughes Incorporated.{{ FIELD }}Successfully defended Edison Chouest Offshore in a DOJ Antitrust Division investigation of its acquisition of Bollinger Shipyards, Inc. in the petroleum offshore services industry.{{ FIELD }}Represented a global energy and petroleum company in an international arbitration involving antitrust and breach of contract claims related to LNG production and distribution.{{ FIELD }}Represented Haddington Ventures, L.L.C. in the acquisition of its gas storage assets.{{ FIELD }}Healthcare/Life Sciences: Successfully defended Piedmont Healthcare, Inc. in a FTC merger investigation of Piedmont’s acquisition of a rival hospital system.{{ FIELD }}Defended a physician member network in a FTC price-fixing investigation.{{ FIELD }}Defended a major pharmaceutical company in a jury trial in United States District Court for the District of Columbia involving antitrust claims arising from exclusive pharmaceutical supply agreements.{{ FIELD }}Represented a leading global branded pharmaceutical company in a DOJ criminal antitrust investigation of a proposed patent settlement with a generic drug company and the use of authorized generics. {{ FIELD }}Antitrust Counseling: Advises clients on antitrust issues arising from everyday business practices, including compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, refusals to deal, and tying/bundling issues.{{ FIELD }}Obtained HSR clearances for hundreds of transactions.{{ FIELD }}Pro Bono Litigation Service:Served as co-lead counsel in a federal habeas death penalty proceeding challenging a pro bono client's Virginia capital murder conviction .  The proceeding culminated in a multi-day evidentiary hearing in federal district court and received national media coverage due to allegations involving extensive drug dealing by Northern Virginia youths, an alleged murder plot, and the Commonwealth's most experienced prosecutors seeking the death penalty.  After federal appellate and district court habeas proceedings, the federal district court issued an opinion vacating our client’s conviction and death sentence, finding violations of fundamental constitutional obligations.{{ FIELD }}Brian Meiners focuses his practice on government antitrust investigations that include criminal and civil matters, merger investigations, and civil litigation. A Partner in our Antitrust practice, Brian represents clients in some of their most complex matters, including global cartel investigations and transactions requiring regulatory approval in multiple jurisdictions. In addition, Brian routinely counsels clients on strategic antitrust issues arising from competitor collaborations, marketing, pricing, distribution practices, and trade association participation. \nBrian was named a “Future Leader” in antitrust law by Global Competition Review in the 2024, 2023, and 2022 publications of Competition Law – Future Leaders. \nBrian appears regularly before the U.S. Department of Justice Antitrust Division and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe.\nHe is a member of the Cartel \u0026amp; Criminal Practice Committee, State Enforcement Committee, and the Mergers \u0026amp; Acquisitions Committee of the American Bar Association, Section of Antitrust Law.\nRecent Presentations and Publications\nPanelist, “Criminal Antitrust Update: DOJ Announces New Policy Regarding Corporate Compliance Programs,” ABA Section of Antitrust Law, Cartel and Criminal Practice Committee (July 2019) \nCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, Antitrust Law Developments (8th ed.) (April 2017)\nCo-author and editor of the Criminal Enforcement chapter of ABA Section of Antitrust Law, 2015 Annual Review of Antitrust Law Developments (March 2016)\nPanelist, “Criminal Antitrust Update,” ABA Section of Antitrust Law, Cartel and Criminal Practice Committee (November 2014)\n“McWane Dismissal May Impact Future FTC Cases,” Competition Law360 (February 2014)\n“Antitrust Bid-Rigging at Natural Gas Auctions,” Competition Law360 (April 2012) \n“Key Takeaways From US v. AU Optronics,” Competition Law360 (March 2012)\nPanelist, “Dawn Raids, Criminalization of Cartels and Beyond: Are You Ready?” King \u0026amp; Spalding and SAI Law \u0026amp; Economics Client Forum (Mexico City, Mexico, November 2011)\nMemberships\nCartel \u0026amp; Criminal Practice Committee, Antitrust Section, American Bar Association\nState Enforcement Committee, Antitrust Section, American Bar Association\nMergers \u0026amp; Acquisitions Committee, Antitrust Section, American Bar Association\nAmerican Health Lawyers Association Partner Texas Christian University  St. Louis University  U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Colorado U.S. District Court for the District of Columbia District of Columbia Missouri Cartel Investigations and Criminal Litigation Experience: Representing a senior executive of an international capacitors manufacturer as lead counsel in connection with a multi-jurisdictional cartel investigation and related civil proceedings. Representing senior executives of multiple international auto parts manufacturers in connection with a multi-jurisdictional cartel investigation in that industry. Represented the chief executive officer of an international TFT-LCD manufacturer in connection with a multi-jurisdictional cartel investigation and related civil proceedings. Represented a senior sales and marketing executive of an international freight consolidator in connection with a multi-jurisdictional cartel investigation and Foreign Corrupt Practices Act investigation.   Civil Antitrust Litigation: Obtained dismissal for a leading national pharmaceutical company in multi-district class action antitrust litigation in In re Generic Pharmaceuticals Pricing Antitrust Litigation. Obtained dismissal in class action antitrust litigation for the United States Postal Service in TOG, Inc. v. United States Postal Service. Obtained dismissal for RLI Insurance Company in multi-district class action antitrust litigation in In re Insurance Brokers Antitrust Litigation. Successfully defended Trelleborg AB in an international arbitration involving antitrust and fraud claims arising from a stock purchase agreement. Energy: \nRepresented Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc. in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world.  Successfully defended Mirant Corporation in a DOJ Second Request investigation of its merger with RRI Energy, creating one of the largest independent power producers in the United States. Successfully defended Varel International Energy Services, Inc. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with its acquisition by Sandvik AB. Successfully defended Weatherford International Ltd. in an investigation by the DOJ Antitrust Division and several foreign competition agencies in connection with the acquisition of its pipeline and specialty services business by Baker Hughes Incorporated. Successfully defended Edison Chouest Offshore in a DOJ Antitrust Division investigation of its acquisition of Bollinger Shipyards, Inc. in the petroleum offshore services industry. Represented a global energy and petroleum company in an international arbitration involving antitrust and breach of contract claims related to LNG production and distribution. Represented Haddington Ventures, L.L.C. in the acquisition of its gas storage assets. Healthcare/Life Sciences: Successfully defended Piedmont Healthcare, Inc. in a FTC merger investigation of Piedmont’s acquisition of a rival hospital system. Defended a physician member network in a FTC price-fixing investigation. Defended a major pharmaceutical company in a jury trial in United States District Court for the District of Columbia involving antitrust claims arising from exclusive pharmaceutical supply agreements. Represented a leading global branded pharmaceutical company in a DOJ criminal antitrust investigation of a proposed patent settlement with a generic drug company and the use of authorized generics.  Antitrust Counseling: Advises clients on antitrust issues arising from everyday business practices, including compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, refusals to deal, and tying/bundling issues. Obtained HSR clearances for hundreds of transactions. Pro Bono Litigation Service:Served as co-lead counsel in a federal habeas death penalty proceeding challenging a pro bono client's Virginia capital murder conviction .  The proceeding culminated in a multi-day evidentiary hearing in federal district court and received national media coverage due to allegations involving extensive drug dealing by Northern Virginia youths, an alleged murder plot, and the Commonwealth's most experienced prosecutors seeking the death penalty.  After federal appellate and district court habeas proceedings, the federal district court issued an opinion vacating our client’s conviction and death sentence, finding violations of fundamental constitutional obligations.","searchable_name":"Brian R. Meiners","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426536,"version":1,"owner_type":"Person","owner_id":4090,"payload":{"bio":"\u003cp\u003eGary Messplay specializes in advising life science companies on regulatory, compliance and transactional matters. A partner in our nationally recognized FDA and Life Sciences practice, Gary has almost 30 years of experience representing large multinational pharmaceutical and medical-device companies, as well as emerging companies.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGary advices clients in matters relating to the approval and commercialization of products that are regulated by the Food\u0026nbsp;and Drug Administration and other federal and state agencies.\u0026nbsp; Gary has substantial experience advising clients on all aspects of product approvals; product launches and commercialization including advertising and promotion; leading compliance-related investigations; developing and implementing regulatory and healthcare compliance programs; advising on patient support programs; and managing competitor disputes.\u0026nbsp; In addition, Gary regularly advises clients on matters relating to healthcare fraud and abuse, clinical trials, informed consent, drug safety issues, product liability, recalls, responding to 483s, warning letters and complete response letters, drug and device quality and manufacturing issues, and life cycle management.\u0026nbsp; Gary also represents companies in transactional matters including distribution and purchasing agreements, pharmacy agreements, clinical trial agreements, payor agreements, manufacturing and supply agreements, physician agreements, research agreements and co-promotion agreements.\u003c/p\u003e\n\u003cp\u003ePreviously, Gary was in-house counsel at Eli Lilly and Company, where he had global legal, regulatory and compliance responsibility for the company's top-selling pharmaceutical product at the time.\u003c/p\u003e\n\u003cp\u003eA frequent author and speaker on regulatory and compliance matters, Gary has been recognized for multiple years by\u0026nbsp;\u003cem\u003eSuper Lawyers Washington, DC\u003c/em\u003e.\u003c/p\u003e","slug":"gary-messplay","email":"gmessplay@kslaw.com","phone":"+1 703 973 7500","matters":["\u003cp\u003eDeveloped customized, comprehensive healthcare compliance programs for numerous \u003cstrong data-redactor-tag=\"strong\"\u003edrug and medical device companies.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eServed as outside general counsel to \u003cstrong data-redactor-tag=\"strong\"\u003especialty pharmaceutical companies and emerging drug and device companies.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eLed significant multi-year investigation for \u003cstrong data-redactor-tag=\"strong\"\u003ea large pharmaceutical company\u003c/strong\u003e involving complex data integrity issues related to their bioanalytics laboratory.\u003c/p\u003e","\u003cp\u003eAdvised numerous \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e related to product commercialization, including advertising and promotion, First Amendment issues, interactions with payors and responding to FDA enforcement.\u003c/p\u003e","\u003cp\u003eConducted a significant number of compliance investigations on behalf of \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies,\u003c/strong\u003e including large multinational investigations, involving off-label promotion, violations of the federal Anti-Kickback Statute and FCPA, whistleblower reports, clinical trial noncompliance, cGMP violations, GLP violations and PDMA/drug sampling.\u003c/p\u003e","\u003cp\u003eRepresented Board of Directors of \u003cstrong data-redactor-tag=\"strong\"\u003epublicly traded pharmaceutical company\u003c/strong\u003e in connection with an investigation involving the company's chief executive officer related to suspected violations of the federal Anti-Kickback Statute.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e on all aspects of compliance with their corporate integrity agreements.\u003c/p\u003e","\u003cp\u003eAdvised numerous \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical companies\u003c/strong\u003e on drug-approval strategies involving NDAs, product life cycle management, Hatch-Waxman and Orange Book issues.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea specialty pharmaceutical company\u003c/strong\u003e in response to a petition filed by a public citizen seeking FDA withdrawal of popular pain medication.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with FDA, OCI, Department of Justice, SEC and congressional investigations.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e related to clinical trial regulatory and compliance issues.\u003c/p\u003e","\u003cp\u003eAssisted \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical companies\u003c/strong\u003e in developing and implementing specialty pharmacy programs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with adverse FDA inspections, including responding to 483s and warning letters.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in transactional matters involving clinical trial agreements, CRO agreements, distribution agreements, specialty pharmacy agreements and all types of services agreements.\u003c/p\u003e","\u003cp\u003eLed numerous regulatory and compliance due diligence teams in \u003cstrong data-redactor-tag=\"strong\"\u003edrug, device, tobacco and food transactions.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with competitor disputes, including serving as trial counsel in major Lanham Act litigation.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug, biotechnology, device, food and tobacco companies\u003c/strong\u003e on legislative matters including drafting and commenting on legislation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":2,"guid":"2.capabilities","index":0,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":5,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":6,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":7,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":8,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Messplay","nick_name":"Gary","clerkships":[],"first_name":"Gary","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"C.","name_suffix":"","recognitions":[{"title":"","detail":"Super Lawyers, 2014, 2015 \u0026 2016"}],"linked_in_url":"https://www.linkedin.com/in/gary-messplay-45599b61/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eGary Messplay specializes in advising life science companies on regulatory, compliance and transactional matters. A partner in our nationally recognized FDA and Life Sciences practice, Gary has almost 30 years of experience representing large multinational pharmaceutical and medical-device companies, as well as emerging companies.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGary advices clients in matters relating to the approval and commercialization of products that are regulated by the Food\u0026nbsp;and Drug Administration and other federal and state agencies.\u0026nbsp; Gary has substantial experience advising clients on all aspects of product approvals; product launches and commercialization including advertising and promotion; leading compliance-related investigations; developing and implementing regulatory and healthcare compliance programs; advising on patient support programs; and managing competitor disputes.\u0026nbsp; In addition, Gary regularly advises clients on matters relating to healthcare fraud and abuse, clinical trials, informed consent, drug safety issues, product liability, recalls, responding to 483s, warning letters and complete response letters, drug and device quality and manufacturing issues, and life cycle management.\u0026nbsp; Gary also represents companies in transactional matters including distribution and purchasing agreements, pharmacy agreements, clinical trial agreements, payor agreements, manufacturing and supply agreements, physician agreements, research agreements and co-promotion agreements.\u003c/p\u003e\n\u003cp\u003ePreviously, Gary was in-house counsel at Eli Lilly and Company, where he had global legal, regulatory and compliance responsibility for the company's top-selling pharmaceutical product at the time.\u003c/p\u003e\n\u003cp\u003eA frequent author and speaker on regulatory and compliance matters, Gary has been recognized for multiple years by\u0026nbsp;\u003cem\u003eSuper Lawyers Washington, DC\u003c/em\u003e.\u003c/p\u003e","matters":["\u003cp\u003eDeveloped customized, comprehensive healthcare compliance programs for numerous \u003cstrong data-redactor-tag=\"strong\"\u003edrug and medical device companies.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eServed as outside general counsel to \u003cstrong data-redactor-tag=\"strong\"\u003especialty pharmaceutical companies and emerging drug and device companies.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eLed significant multi-year investigation for \u003cstrong data-redactor-tag=\"strong\"\u003ea large pharmaceutical company\u003c/strong\u003e involving complex data integrity issues related to their bioanalytics laboratory.\u003c/p\u003e","\u003cp\u003eAdvised numerous \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e related to product commercialization, including advertising and promotion, First Amendment issues, interactions with payors and responding to FDA enforcement.\u003c/p\u003e","\u003cp\u003eConducted a significant number of compliance investigations on behalf of \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies,\u003c/strong\u003e including large multinational investigations, involving off-label promotion, violations of the federal Anti-Kickback Statute and FCPA, whistleblower reports, clinical trial noncompliance, cGMP violations, GLP violations and PDMA/drug sampling.\u003c/p\u003e","\u003cp\u003eRepresented Board of Directors of \u003cstrong data-redactor-tag=\"strong\"\u003epublicly traded pharmaceutical company\u003c/strong\u003e in connection with an investigation involving the company's chief executive officer related to suspected violations of the federal Anti-Kickback Statute.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e on all aspects of compliance with their corporate integrity agreements.\u003c/p\u003e","\u003cp\u003eAdvised numerous \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical companies\u003c/strong\u003e on drug-approval strategies involving NDAs, product life cycle management, Hatch-Waxman and Orange Book issues.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea specialty pharmaceutical company\u003c/strong\u003e in response to a petition filed by a public citizen seeking FDA withdrawal of popular pain medication.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with FDA, OCI, Department of Justice, SEC and congressional investigations.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e related to clinical trial regulatory and compliance issues.\u003c/p\u003e","\u003cp\u003eAssisted \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical companies\u003c/strong\u003e in developing and implementing specialty pharmacy programs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with adverse FDA inspections, including responding to 483s and warning letters.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in transactional matters involving clinical trial agreements, CRO agreements, distribution agreements, specialty pharmacy agreements and all types of services agreements.\u003c/p\u003e","\u003cp\u003eLed numerous regulatory and compliance due diligence teams in \u003cstrong data-redactor-tag=\"strong\"\u003edrug, device, tobacco and food transactions.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003edrug and device companies\u003c/strong\u003e in connection with competitor disputes, including serving as trial counsel in major Lanham Act litigation.\u003c/p\u003e","\u003cp\u003eAdvised \u003cstrong data-redactor-tag=\"strong\"\u003edrug, biotechnology, device, food and tobacco companies\u003c/strong\u003e on legislative matters including drafting and commenting on legislation.\u003c/p\u003e"],"recognitions":[{"title":"","detail":"Super Lawyers, 2014, 2015 \u0026 2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4357}]},"capability_group_id":2},"created_at":"2025-05-26T04:54:29.000Z","updated_at":"2025-05-26T04:54:29.000Z","searchable_text":"Messplay{{ FIELD }}{:title=\u0026gt;\"\", :detail=\u0026gt;\"Super Lawyers, 2014, 2015 \u0026amp; 2016\"}{{ FIELD }}Developed customized, comprehensive healthcare compliance programs for numerous drug and medical device companies.{{ FIELD }}Served as outside general counsel to specialty pharmaceutical companies and emerging drug and device companies.{{ FIELD }}Led significant multi-year investigation for a large pharmaceutical company involving complex data integrity issues related to their bioanalytics laboratory.{{ FIELD }}Advised numerous drug and device companies related to product commercialization, including advertising and promotion, First Amendment issues, interactions with payors and responding to FDA enforcement.{{ FIELD }}Conducted a significant number of compliance investigations on behalf of drug and device companies, including large multinational investigations, involving off-label promotion, violations of the federal Anti-Kickback Statute and FCPA, whistleblower reports, clinical trial noncompliance, cGMP violations, GLP violations and PDMA/drug sampling.{{ FIELD }}Represented Board of Directors of publicly traded pharmaceutical company in connection with an investigation involving the company's chief executive officer related to suspected violations of the federal Anti-Kickback Statute.{{ FIELD }}Advised drug and device companies on all aspects of compliance with their corporate integrity agreements.{{ FIELD }}Advised numerous pharmaceutical companies on drug-approval strategies involving NDAs, product life cycle management, Hatch-Waxman and Orange Book issues.{{ FIELD }}Successfully represented a specialty pharmaceutical company in response to a petition filed by a public citizen seeking FDA withdrawal of popular pain medication.{{ FIELD }}Represented drug and device companies in connection with FDA, OCI, Department of Justice, SEC and congressional investigations.{{ FIELD }}Advised drug and device companies related to clinical trial regulatory and compliance issues.{{ FIELD }}Assisted pharmaceutical companies in developing and implementing specialty pharmacy programs.{{ FIELD }}Represented drug and device companies in connection with adverse FDA inspections, including responding to 483s and warning letters.{{ FIELD }}Represented drug and device companies in transactional matters involving clinical trial agreements, CRO agreements, distribution agreements, specialty pharmacy agreements and all types of services agreements.{{ FIELD }}Led numerous regulatory and compliance due diligence teams in drug, device, tobacco and food transactions.{{ FIELD }}Represented drug and device companies in connection with competitor disputes, including serving as trial counsel in major Lanham Act litigation.{{ FIELD }}Advised drug, biotechnology, device, food and tobacco companies on legislative matters including drafting and commenting on legislation.{{ FIELD }}Gary Messplay specializes in advising life science companies on regulatory, compliance and transactional matters. A partner in our nationally recognized FDA and Life Sciences practice, Gary has almost 30 years of experience representing large multinational pharmaceutical and medical-device companies, as well as emerging companies.\nGary advices clients in matters relating to the approval and commercialization of products that are regulated by the Food and Drug Administration and other federal and state agencies.  Gary has substantial experience advising clients on all aspects of product approvals; product launches and commercialization including advertising and promotion; leading compliance-related investigations; developing and implementing regulatory and healthcare compliance programs; advising on patient support programs; and managing competitor disputes.  In addition, Gary regularly advises clients on matters relating to healthcare fraud and abuse, clinical trials, informed consent, drug safety issues, product liability, recalls, responding to 483s, warning letters and complete response letters, drug and device quality and manufacturing issues, and life cycle management.  Gary also represents companies in transactional matters including distribution and purchasing agreements, pharmacy agreements, clinical trial agreements, payor agreements, manufacturing and supply agreements, physician agreements, research agreements and co-promotion agreements.\nPreviously, Gary was in-house counsel at Eli Lilly and Company, where he had global legal, regulatory and compliance responsibility for the company's top-selling pharmaceutical product at the time.\nA frequent author and speaker on regulatory and compliance matters, Gary has been recognized for multiple years by Super Lawyers Washington, DC. Partner  Super Lawyers, 2014, 2015 \u0026amp; 2016 District of Columbia Indiana Developed customized, comprehensive healthcare compliance programs for numerous drug and medical device companies. Served as outside general counsel to specialty pharmaceutical companies and emerging drug and device companies. Led significant multi-year investigation for a large pharmaceutical company involving complex data integrity issues related to their bioanalytics laboratory. Advised numerous drug and device companies related to product commercialization, including advertising and promotion, First Amendment issues, interactions with payors and responding to FDA enforcement. Conducted a significant number of compliance investigations on behalf of drug and device companies, including large multinational investigations, involving off-label promotion, violations of the federal Anti-Kickback Statute and FCPA, whistleblower reports, clinical trial noncompliance, cGMP violations, GLP violations and PDMA/drug sampling. Represented Board of Directors of publicly traded pharmaceutical company in connection with an investigation involving the company's chief executive officer related to suspected violations of the federal Anti-Kickback Statute. Advised drug and device companies on all aspects of compliance with their corporate integrity agreements. Advised numerous pharmaceutical companies on drug-approval strategies involving NDAs, product life cycle management, Hatch-Waxman and Orange Book issues. Successfully represented a specialty pharmaceutical company in response to a petition filed by a public citizen seeking FDA withdrawal of popular pain medication. Represented drug and device companies in connection with FDA, OCI, Department of Justice, SEC and congressional investigations. Advised drug and device companies related to clinical trial regulatory and compliance issues. Assisted pharmaceutical companies in developing and implementing specialty pharmacy programs. Represented drug and device companies in connection with adverse FDA inspections, including responding to 483s and warning letters. Represented drug and device companies in transactional matters involving clinical trial agreements, CRO agreements, distribution agreements, specialty pharmacy agreements and all types of services agreements. Led numerous regulatory and compliance due diligence teams in drug, device, tobacco and food transactions. Represented drug and device companies in connection with competitor disputes, including serving as trial counsel in major Lanham Act litigation. Advised drug, biotechnology, device, food and tobacco companies on legislative matters including drafting and commenting on legislation.","searchable_name":"Gary C. Messplay","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":426357,"version":1,"owner_type":"Person","owner_id":2817,"payload":{"bio":"\u003cp\u003eAs a partner in our Appellate, Constitutional and Administrative Law practice, Paul Mezzina focuses on appeals, critical motions and strategic counseling in connection with complex litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePaul represents clients in a variety of matters, including those involving the False Claims Act, intellectual property, class actions, medical drugs and devices, antitrust, and professional liability.\u003c/p\u003e\n\u003cp\u003ePaul has authored briefs in numerous cases before the U.S. Supreme Court, federal courts of appeals and federal trial courts, and has presented oral argument in the Second, Fourth, Tenth, Eleventh, D.C. and Federal Circuits, as well as multiple state courts.\u003c/p\u003e\n\u003cp\u003ePaul is one of few attorneys in the country to have clerked for three U.S. Supreme Court Justices.\u003c/p\u003e","slug":"paul-mezzina","email":"pmezzina@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":2,"source":"smartTags"},{"id":21,"guid":"21.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":18,"guid":"18.capabilities","index":5,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":6,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":7,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":8,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":9,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":10,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":11,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":12,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":13,"source":"smartTags"}],"is_active":true,"last_name":"Mezzina","nick_name":"Paul","clerkships":[{"name":"Law Clerk, Justice Antonin Scalia, Supreme Court of the United States","years_held":"2013-2014"},{"name":"Law Clerk, Judge Brett Kavanaugh, U.S. Court of Appeals for the D.C. Circuit","years_held":"2009-2010"},{"name":"Law Clerk, Justice Neil Gorsuch, Supreme Court of the United States","years_held":"2018 - 2019"}],"first_name":"Paul","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"Alessio","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/paulmezzina/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a partner in our Appellate, Constitutional and Administrative Law practice, Paul Mezzina focuses on appeals, critical motions and strategic counseling in connection with complex litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePaul represents clients in a variety of matters, including those involving the False Claims Act, intellectual property, class actions, medical drugs and devices, antitrust, and professional liability.\u003c/p\u003e\n\u003cp\u003ePaul has authored briefs in numerous cases before the U.S. Supreme Court, federal courts of appeals and federal trial courts, and has presented oral argument in the Second, Fourth, Tenth, Eleventh, D.C. and Federal Circuits, as well as multiple state courts.\u003c/p\u003e\n\u003cp\u003ePaul is one of few attorneys in the country to have clerked for three U.S. Supreme Court Justices.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":70}]},"capability_group_id":3},"created_at":"2025-05-26T04:51:47.000Z","updated_at":"2025-05-26T04:51:47.000Z","searchable_text":"Mezzina{{ FIELD }}As a partner in our Appellate, Constitutional and Administrative Law practice, Paul Mezzina focuses on appeals, critical motions and strategic counseling in connection with complex litigation.\nPaul represents clients in a variety of matters, including those involving the False Claims Act, intellectual property, class actions, medical drugs and devices, antitrust, and professional liability.\nPaul has authored briefs in numerous cases before the U.S. Supreme Court, federal courts of appeals and federal trial courts, and has presented oral argument in the Second, Fourth, Tenth, Eleventh, D.C. and Federal Circuits, as well as multiple state courts.\nPaul is one of few attorneys in the country to have clerked for three U.S. Supreme Court Justices. Partner Harvard University Harvard Law School Harvard University Harvard Law School U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the First Circuit U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Tenth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Central District of California U.S. District Court for the District of Columbia District of Columbia Law Clerk, Justice Antonin Scalia, Supreme Court of the United States Law Clerk, Judge Brett Kavanaugh, U.S. Court of Appeals for the D.C. Circuit Law Clerk, Justice Neil Gorsuch, Supreme Court of the United States","searchable_name":"Paul Alessio Mezzina","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":445015,"version":1,"owner_type":"Person","owner_id":6258,"payload":{"bio":"\u003cp\u003eBrian Miller focuses his practice on securities class action defense, SEC investigations, internal investigations of whistleblower allegations, accounting fraud, fiduciary duties, private credit disputes, partnership disputes, healthcare disputes, and other commercial disputes. Brian has defended dozens of shareholder class actions alleging securities fraud, accounting fraud, and breach of fiduciary duty. Collectively, these matters have sought damages in the billions of dollars.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrian represents public companies and their directors and officers, private equity and private credit funds, borrowers from private credit funds, registered investment advisors, and individual and corporate clients facing SEC investigations and bet-the-company litigation, typically involving fraud or breach of fiduciary duty allegations. He also has significant experience litigating commercial disputes throughout Florida, in state and federal courts as well as private arbitration tribunals.\u0026nbsp;Many of his cases involve multiple related lawsuits and pending government or regulatory investigations in different jurisdictions across the United States and internationally.\u003c/p\u003e\n\u003cp\u003eBrian draws upon his experience as a former SEC lawyer to represent his clients. Brian began his career at the SEC in Washington, D.C., where, among other things, he served as special counsel to Commissioner Steven M.H. Wallman. He is recognized annually by\u0026nbsp;\u003cem\u003eBenchmark Litigation\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eThe Best Lawyers in America \u003c/em\u003eand is ranked Band 1 by \u003cem\u003eChambers USA \u003c/em\u003ein \u0026ldquo;Litigation: Securities \u0026ndash; Florida\u0026rdquo;\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","slug":"brian-miller","email":"bmiller@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eRepresentative Trial Experience\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended private equity fund against allegations of breach of fiduciary duty in a nine-week trial.\u003c/p\u003e","\u003cp\u003eDefended Latin American businessman on $30 million fraud and breach of promissory note claims in federal bankruptcy court trial.\u003c/p\u003e","\u003cp\u003eDefended SEC claims against alleged unregistered broker dealer in federal court trial.\u003c/p\u003e","\u003cp\u003eProsecuted trial claims on behalf of private country club related to $850,000 annual special assessment.\u003c/p\u003e","\u003cp\u003eProsecuted claims on behalf of Bahraini pharmaceutical company against US machinery supplier in arbitration.\u003c/p\u003e","\u003cp\u003eDefended SEC claims against CEO of public company in federal court trial.\u003c/p\u003e","\u003cp\u003eDefended breach of fiduciary duty claims against public company in connection with merger transaction.\u003c/p\u003e","\u003cp\u003eProsecuted several pro bono trials on behalf of prisoners alleging civil rights violations.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eInternal Investigations\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented audit committee of construction firm in connection with internal investigation arising from whistleblower allegations of accounting irregularities.\u003c/p\u003e\n\u003cp\u003eInvestigated alleged stock-option backdating on behalf of audit committee of NASDAQ-traded public company in the telecommunications industry.\u003c/p\u003e\n\u003cp\u003eInvestigated allegations of dishonest conduct by senior financial personnel of NYSE-traded public company in the telecommunications industry.\u003c/p\u003e\n\u003cp\u003eRepresented audit committee of NYSE-traded public company in the real estate industry in two separate internal investigations arising from whistleblower allegations of accounting and other fraud.\u003c/p\u003e\n\u003cp\u003eInvestigated accounting fraud allegations on behalf of audit committee of NASDAQ-traded company in the pharmaceutical industry.\u003c/p\u003e\n\u003cp\u003eInvestigated inventory accounting fraud allegations for Amex-traded public company in the aerospace industry.\u003c/p\u003e\n\u003cp\u003eInvestigated allegations of insider trading by officer of Nasdaq-traded bank holding company.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSecurities Class Action Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against medical device manufacturer related to disclosures about the status of new product development. Dismissal affirmed on appeal.\u003c/p\u003e\n\u003cp\u003eDefended public correctional facilities company in defense of federal securities claims related to COVID-19 and disclosures.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against VOIP telecommunications company.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against a public company in the education industry alleging accounting and other misstatements.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against staffing company.\u003c/p\u003e\n\u003cp\u003eRepresented hedge fund and its principal in defense of securities class action and parallel derivative claims regarding stock buyback.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against semiconductor company alleging fraud in connection with revision to earnings guidance.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims related to earnings miss by NYSE-traded solid waste disposal company.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against pharmaceutical company related to status of new product development.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims related to earnings miss and alleged accounting improprieties for a software-development company.\u003c/p\u003e\n\u003cp\u003eRepresented former CEO of bankrupt software company in multidistrict federal securities fraud litigation alleging accounting and related-party-disclosure improprieties.\u003c/p\u003e\n\u003cp\u003eDefended Big 4 accounting firm in federal securities class action.\u003c/p\u003e\n\u003cp\u003eRepresented aerospace company in defending federal class action securities claims alleging revenue recognition violations after restatement of five years\u0026rsquo; financial statements.\u003c/p\u003e\n\u003cp\u003eRepresented former controller of bankrupt time-share company in federal class action securities claims alleging accounting misstatements related to $130 million impairment charge.\u003c/p\u003e\n\u003cp\u003eRepresented directors and officers of bankrupt telecommunications infrastructure company in federal class action securities claims alleging financial misstatements.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAntitakeover and M\u0026amp;A Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented health insurance company in defense of claims seeking to enjoin $12.8 billion merger.\u003c/p\u003e\n\u003cp\u003eDefeated preliminary injunction in Maryland litigation seeking to enjoin $84 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented sports merchandising company in defense of claims seeking to enjoin $185 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented private equity fund in litigation seeking to enjoin going-private transaction.\u003c/p\u003e\n\u003cp\u003eRepresented healthcare company in litigation seeking to enjoin $1.1 billion merger transaction.\u003c/p\u003e\n\u003cp\u003eDefended preliminary injunction proceeding in Florida state court regarding a $500 million merger for a public company in the security industry.\u003c/p\u003e\n\u003cp\u003eDefended preliminary injunction regarding a $50 million public company merger.\u003c/p\u003e\n\u003cp\u003eRepresented NASDAQ-traded physician services company regarding a $1.1 billion going-private merger.\u003c/p\u003e\n\u003cp\u003eRepresented waste services company in defense of multistate litigation seeking to enjoin $6 billion merger involving an unsolicited hostile takeover bid.\u003c/p\u003e\n\u003cp\u003eRepresented timeshare company in multi-state litigation seeking to enjoin stock-for-stock merger, involving hostile takeover bid.\u003c/p\u003e\n\u003cp\u003eRepresented retailer in litigation seeking to enjoin $150 million merger transaction.\u003c/p\u003e\n\u003cp\u003eRepresented acquiror of publicly traded correctional properties company in Maryland and Florida state-court actions seeking to enjoin $300 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented acquiror of health products distributor in Florida state-court class action seeking to enjoin acquisition of public company.\u003c/p\u003e\n\u003cp\u003eAdvised management of companies considering hostile takeover of competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSEC Enforcement Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multiple clients at trial against SEC charges.\u003c/p\u003e\n\u003cp\u003eRepresented former CEO of software company in an SEC enforcement proceeding.\u003c/p\u003e\n\u003cp\u003eRepresented Latin American investment company in defense of SEC enforcement proceeding relating to broker-dealer registration.\u003c/p\u003e\n\u003cp\u003eRepresented private company in the direct marketing industry related to alleged market manipulation.\u003c/p\u003e\n\u003cp\u003eRepresented aerospace company, in the face of related criminal proceedings against company\u0026rsquo;s CEO and CFO, related to alleged revenue recognition violations stemming from restatement of multiple years\u0026rsquo; financial statements.\u003c/p\u003e\n\u003cp\u003eRepresented former consultant to telecommunications equipment company in SEC investigation of alleged accounting improprieties.\u003c/p\u003e\n\u003cp\u003eRepresented NYSE-traded company in SEC informal inquiry concerning disposition of European assets.\u003c/p\u003e\n\u003cp\u003eRepresented former officer of nutrition supplement company in SEC investigation related to alleged revenue recognition issues.\u003c/p\u003e\n\u003cp\u003eRepresented individuals in SEC investigation related to alleged Finders\u0026rsquo; Fees.\u003c/p\u003e\n\u003cp\u003eRepresented numerous individuals in SEC enforcement action related to alleged insider trading.\u003c/p\u003e\n\u003cp\u003eRepresented certified public accountant in Rule 102(e) proceeding.\u003c/p\u003e\n\u003cp\u003eRepresented broker-dealer in Florida state investigation regarding auction-rate securities.\u003c/p\u003e\n\u003cp\u003eRepresented numerous public companies in SEC and SRO investigations of pre-announcement trading activity related to announced merger transactions.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOther Accounting and Financial Fraud Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented crypto mining support company in novel antitrust claims related to Bitcoin.\u003c/p\u003e\n\u003cp\u003eRepresented private equity fund in defense of multiple lawsuits in New York federal and state courts alleging fraudulent accounts receivable.\u003c/p\u003e\n\u003cp\u003eDefended public companies in class actions alleging unfair and deceptive trade practices.\u003c/p\u003e\n\u003cp\u003eRepresented directors of television broadcasting company in defense of claims brought by bankruptcy trustee.\u003c/p\u003e\n\u003cp\u003eOpposed remand to state court for Internet company in suit seeking rescission by investors.\u003c/p\u003e\n\u003cp\u003eRepresented Amex-traded public company in the pharmaceutical industry in federal court and arbitration against German company alleging accounting improprieties in connection with an earnout agreement.\u003c/p\u003e\n\u003cp\u003eRepresented Central Bank of Ecuador in banking fraud litigation pending in The Bahamas.\u003c/p\u003e\n\u003cp\u003eRepresented U.S. railroad in accounting arbitration related to shipping rates.\u003c/p\u003e\n\u003cp\u003eRepresented receiver over $100 million assets in dispute regarding an educational institution in the Caribbean.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOther Shareholder Derivative Litigation Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended executive of a private equity fund at trial in defense of derivative claims brought by investor related to M\u0026amp;A transactions.\u003c/p\u003e\n\u003cp\u003eRepresented directors of a publicly traded entertainment company related to the acquisition of a business from an affiliate.\u003c/p\u003e\n\u003cp\u003eRepresented public company in the education industry in defending derivative claims arising from parallel criminal and SEC investigations.\u003c/p\u003e\n\u003cp\u003eRepresented directors and officers of private restaurant company in arbitration alleging mismanagement.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eLodging \u0026amp; Lifestyle\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented private country club at trial against municipality.\u003c/p\u003e\n\u003cp\u003eRepresented public vacation ownership (timeshare) company in defense of multi-jurisdiction state court class actions.\u003c/p\u003e\n\u003cp\u003eRepresented hotel company in defense of federal class action and related derivative litigation.\u003c/p\u003e\n\u003cp\u003eRepresented owners of condo hotel project in federal mass-action litigation against developer.\u003c/p\u003e\n\u003cp\u003eRepresented online travel booking website in various matters.\u003c/p\u003e\n\u003cp\u003eRepresented officer of public vacation ownership (timeshare) company in federal class action.\u003c/p\u003e\n\u003cp\u003eRepresented Mexican restaurant chain in Texas state court litigation and arbitration.\u003c/p\u003e\n\u003cp\u003eRepresented hotel company in litigation in Arizona state court.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":1,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":766,"guid":"766.smart_tags","index":8,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":5,"guid":"5.smart_tags","index":10,"source":"smartTags"},{"id":607,"guid":"607.smart_tags","index":11,"source":"smartTags"},{"id":1715,"guid":"1715.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Miller","nick_name":"Brian","clerkships":[],"first_name":"Brian","title_rank":9999,"updated_by":202,"law_schools":[{"id":345,"meta":{"degree":"J.D.","honors":"summa cum laude","is_law_school":"1","graduation_date":"1993-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"P.","name_suffix":"","recognitions":[{"title":"Ranked Band 1","detail":"Chambers USA in Litigation: Securities – Florida"},{"title":"Recognized for Commercial Litigation and Litigation – Securities in Florida","detail":"The Best Lawyers in America 2012-2021"},{"title":"Named a “Litigation Star” for General Commercial and Securities in Florida","detail":"Benchmark Litigation 2014-2021, 2023"},{"title":"Recognized as a “Top Rated Securities Litigation Attorney in Miami, FL","detail":"Super Lawyers Magazine 2009-2022"}],"linked_in_url":"https://www.linkedin.com/in/brian-miller-73393627/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBrian Miller focuses his practice on securities class action defense, SEC investigations, internal investigations of whistleblower allegations, accounting fraud, fiduciary duties, private credit disputes, partnership disputes, healthcare disputes, and other commercial disputes. Brian has defended dozens of shareholder class actions alleging securities fraud, accounting fraud, and breach of fiduciary duty. Collectively, these matters have sought damages in the billions of dollars.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrian represents public companies and their directors and officers, private equity and private credit funds, borrowers from private credit funds, registered investment advisors, and individual and corporate clients facing SEC investigations and bet-the-company litigation, typically involving fraud or breach of fiduciary duty allegations. He also has significant experience litigating commercial disputes throughout Florida, in state and federal courts as well as private arbitration tribunals.\u0026nbsp;Many of his cases involve multiple related lawsuits and pending government or regulatory investigations in different jurisdictions across the United States and internationally.\u003c/p\u003e\n\u003cp\u003eBrian draws upon his experience as a former SEC lawyer to represent his clients. Brian began his career at the SEC in Washington, D.C., where, among other things, he served as special counsel to Commissioner Steven M.H. Wallman. He is recognized annually by\u0026nbsp;\u003cem\u003eBenchmark Litigation\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eThe Best Lawyers in America \u003c/em\u003eand is ranked Band 1 by \u003cem\u003eChambers USA \u003c/em\u003ein \u0026ldquo;Litigation: Securities \u0026ndash; Florida\u0026rdquo;\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eRepresentative Trial Experience\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended private equity fund against allegations of breach of fiduciary duty in a nine-week trial.\u003c/p\u003e","\u003cp\u003eDefended Latin American businessman on $30 million fraud and breach of promissory note claims in federal bankruptcy court trial.\u003c/p\u003e","\u003cp\u003eDefended SEC claims against alleged unregistered broker dealer in federal court trial.\u003c/p\u003e","\u003cp\u003eProsecuted trial claims on behalf of private country club related to $850,000 annual special assessment.\u003c/p\u003e","\u003cp\u003eProsecuted claims on behalf of Bahraini pharmaceutical company against US machinery supplier in arbitration.\u003c/p\u003e","\u003cp\u003eDefended SEC claims against CEO of public company in federal court trial.\u003c/p\u003e","\u003cp\u003eDefended breach of fiduciary duty claims against public company in connection with merger transaction.\u003c/p\u003e","\u003cp\u003eProsecuted several pro bono trials on behalf of prisoners alleging civil rights violations.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eInternal Investigations\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented audit committee of construction firm in connection with internal investigation arising from whistleblower allegations of accounting irregularities.\u003c/p\u003e\n\u003cp\u003eInvestigated alleged stock-option backdating on behalf of audit committee of NASDAQ-traded public company in the telecommunications industry.\u003c/p\u003e\n\u003cp\u003eInvestigated allegations of dishonest conduct by senior financial personnel of NYSE-traded public company in the telecommunications industry.\u003c/p\u003e\n\u003cp\u003eRepresented audit committee of NYSE-traded public company in the real estate industry in two separate internal investigations arising from whistleblower allegations of accounting and other fraud.\u003c/p\u003e\n\u003cp\u003eInvestigated accounting fraud allegations on behalf of audit committee of NASDAQ-traded company in the pharmaceutical industry.\u003c/p\u003e\n\u003cp\u003eInvestigated inventory accounting fraud allegations for Amex-traded public company in the aerospace industry.\u003c/p\u003e\n\u003cp\u003eInvestigated allegations of insider trading by officer of Nasdaq-traded bank holding company.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSecurities Class Action Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against medical device manufacturer related to disclosures about the status of new product development. Dismissal affirmed on appeal.\u003c/p\u003e\n\u003cp\u003eDefended public correctional facilities company in defense of federal securities claims related to COVID-19 and disclosures.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against VOIP telecommunications company.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against a public company in the education industry alleging accounting and other misstatements.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against staffing company.\u003c/p\u003e\n\u003cp\u003eRepresented hedge fund and its principal in defense of securities class action and parallel derivative claims regarding stock buyback.\u003c/p\u003e\n\u003cp\u003eDefended federal securities class action against semiconductor company alleging fraud in connection with revision to earnings guidance.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims related to earnings miss by NYSE-traded solid waste disposal company.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims against pharmaceutical company related to status of new product development.\u003c/p\u003e\n\u003cp\u003eDefended federal class action securities claims related to earnings miss and alleged accounting improprieties for a software-development company.\u003c/p\u003e\n\u003cp\u003eRepresented former CEO of bankrupt software company in multidistrict federal securities fraud litigation alleging accounting and related-party-disclosure improprieties.\u003c/p\u003e\n\u003cp\u003eDefended Big 4 accounting firm in federal securities class action.\u003c/p\u003e\n\u003cp\u003eRepresented aerospace company in defending federal class action securities claims alleging revenue recognition violations after restatement of five years\u0026rsquo; financial statements.\u003c/p\u003e\n\u003cp\u003eRepresented former controller of bankrupt time-share company in federal class action securities claims alleging accounting misstatements related to $130 million impairment charge.\u003c/p\u003e\n\u003cp\u003eRepresented directors and officers of bankrupt telecommunications infrastructure company in federal class action securities claims alleging financial misstatements.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAntitakeover and M\u0026amp;A Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented health insurance company in defense of claims seeking to enjoin $12.8 billion merger.\u003c/p\u003e\n\u003cp\u003eDefeated preliminary injunction in Maryland litigation seeking to enjoin $84 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented sports merchandising company in defense of claims seeking to enjoin $185 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented private equity fund in litigation seeking to enjoin going-private transaction.\u003c/p\u003e\n\u003cp\u003eRepresented healthcare company in litigation seeking to enjoin $1.1 billion merger transaction.\u003c/p\u003e\n\u003cp\u003eDefended preliminary injunction proceeding in Florida state court regarding a $500 million merger for a public company in the security industry.\u003c/p\u003e\n\u003cp\u003eDefended preliminary injunction regarding a $50 million public company merger.\u003c/p\u003e\n\u003cp\u003eRepresented NASDAQ-traded physician services company regarding a $1.1 billion going-private merger.\u003c/p\u003e\n\u003cp\u003eRepresented waste services company in defense of multistate litigation seeking to enjoin $6 billion merger involving an unsolicited hostile takeover bid.\u003c/p\u003e\n\u003cp\u003eRepresented timeshare company in multi-state litigation seeking to enjoin stock-for-stock merger, involving hostile takeover bid.\u003c/p\u003e\n\u003cp\u003eRepresented retailer in litigation seeking to enjoin $150 million merger transaction.\u003c/p\u003e\n\u003cp\u003eRepresented acquiror of publicly traded correctional properties company in Maryland and Florida state-court actions seeking to enjoin $300 million merger.\u003c/p\u003e\n\u003cp\u003eRepresented acquiror of health products distributor in Florida state-court class action seeking to enjoin acquisition of public company.\u003c/p\u003e\n\u003cp\u003eAdvised management of companies considering hostile takeover of competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSEC Enforcement Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multiple clients at trial against SEC charges.\u003c/p\u003e\n\u003cp\u003eRepresented former CEO of software company in an SEC enforcement proceeding.\u003c/p\u003e\n\u003cp\u003eRepresented Latin American investment company in defense of SEC enforcement proceeding relating to broker-dealer registration.\u003c/p\u003e\n\u003cp\u003eRepresented private company in the direct marketing industry related to alleged market manipulation.\u003c/p\u003e\n\u003cp\u003eRepresented aerospace company, in the face of related criminal proceedings against company\u0026rsquo;s CEO and CFO, related to alleged revenue recognition violations stemming from restatement of multiple years\u0026rsquo; financial statements.\u003c/p\u003e\n\u003cp\u003eRepresented former consultant to telecommunications equipment company in SEC investigation of alleged accounting improprieties.\u003c/p\u003e\n\u003cp\u003eRepresented NYSE-traded company in SEC informal inquiry concerning disposition of European assets.\u003c/p\u003e\n\u003cp\u003eRepresented former officer of nutrition supplement company in SEC investigation related to alleged revenue recognition issues.\u003c/p\u003e\n\u003cp\u003eRepresented individuals in SEC investigation related to alleged Finders\u0026rsquo; Fees.\u003c/p\u003e\n\u003cp\u003eRepresented numerous individuals in SEC enforcement action related to alleged insider trading.\u003c/p\u003e\n\u003cp\u003eRepresented certified public accountant in Rule 102(e) proceeding.\u003c/p\u003e\n\u003cp\u003eRepresented broker-dealer in Florida state investigation regarding auction-rate securities.\u003c/p\u003e\n\u003cp\u003eRepresented numerous public companies in SEC and SRO investigations of pre-announcement trading activity related to announced merger transactions.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOther Accounting and Financial Fraud Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented crypto mining support company in novel antitrust claims related to Bitcoin.\u003c/p\u003e\n\u003cp\u003eRepresented private equity fund in defense of multiple lawsuits in New York federal and state courts alleging fraudulent accounts receivable.\u003c/p\u003e\n\u003cp\u003eDefended public companies in class actions alleging unfair and deceptive trade practices.\u003c/p\u003e\n\u003cp\u003eRepresented directors of television broadcasting company in defense of claims brought by bankruptcy trustee.\u003c/p\u003e\n\u003cp\u003eOpposed remand to state court for Internet company in suit seeking rescission by investors.\u003c/p\u003e\n\u003cp\u003eRepresented Amex-traded public company in the pharmaceutical industry in federal court and arbitration against German company alleging accounting improprieties in connection with an earnout agreement.\u003c/p\u003e\n\u003cp\u003eRepresented Central Bank of Ecuador in banking fraud litigation pending in The Bahamas.\u003c/p\u003e\n\u003cp\u003eRepresented U.S. railroad in accounting arbitration related to shipping rates.\u003c/p\u003e\n\u003cp\u003eRepresented receiver over $100 million assets in dispute regarding an educational institution in the Caribbean.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOther Shareholder Derivative Litigation Defense\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended executive of a private equity fund at trial in defense of derivative claims brought by investor related to M\u0026amp;A transactions.\u003c/p\u003e\n\u003cp\u003eRepresented directors of a publicly traded entertainment company related to the acquisition of a business from an affiliate.\u003c/p\u003e\n\u003cp\u003eRepresented public company in the education industry in defending derivative claims arising from parallel criminal and SEC investigations.\u003c/p\u003e\n\u003cp\u003eRepresented directors and officers of private restaurant company in arbitration alleging mismanagement.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eLodging \u0026amp; Lifestyle\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented private country club at trial against municipality.\u003c/p\u003e\n\u003cp\u003eRepresented public vacation ownership (timeshare) company in defense of multi-jurisdiction state court class actions.\u003c/p\u003e\n\u003cp\u003eRepresented hotel company in defense of federal class action and related derivative litigation.\u003c/p\u003e\n\u003cp\u003eRepresented owners of condo hotel project in federal mass-action litigation against developer.\u003c/p\u003e\n\u003cp\u003eRepresented online travel booking website in various matters.\u003c/p\u003e\n\u003cp\u003eRepresented officer of public vacation ownership (timeshare) company in federal class action.\u003c/p\u003e\n\u003cp\u003eRepresented Mexican restaurant chain in Texas state court litigation and arbitration.\u003c/p\u003e\n\u003cp\u003eRepresented hotel company in litigation in Arizona state court.\u003c/p\u003e"],"recognitions":[{"title":"Ranked Band 1","detail":"Chambers USA in Litigation: Securities – Florida"},{"title":"Recognized for Commercial Litigation and Litigation – Securities in Florida","detail":"The Best Lawyers in America 2012-2021"},{"title":"Named a “Litigation Star” for General Commercial and Securities in Florida","detail":"Benchmark Litigation 2014-2021, 2023"},{"title":"Recognized as a “Top Rated Securities Litigation Attorney in Miami, FL","detail":"Super Lawyers Magazine 2009-2022"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9669}]},"capability_group_id":3},"created_at":"2026-01-13T21:31:45.000Z","updated_at":"2026-01-13T21:31:45.000Z","searchable_text":"Miller{{ FIELD }}{:title=\u0026gt;\"Ranked Band 1\", :detail=\u0026gt;\"Chambers USA in Litigation: Securities – Florida\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for Commercial Litigation and Litigation – Securities in Florida\", :detail=\u0026gt;\"The Best Lawyers in America 2012-2021\"}{{ FIELD }}{:title=\u0026gt;\"Named a “Litigation Star” for General Commercial and Securities in Florida\", :detail=\u0026gt;\"Benchmark Litigation 2014-2021, 2023\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a “Top Rated Securities Litigation Attorney in Miami, FL\", :detail=\u0026gt;\"Super Lawyers Magazine 2009-2022\"}{{ FIELD }}Representative Trial Experience\nDefended private equity fund against allegations of breach of fiduciary duty in a nine-week trial.{{ FIELD }}Defended Latin American businessman on $30 million fraud and breach of promissory note claims in federal bankruptcy court trial.{{ FIELD }}Defended SEC claims against alleged unregistered broker dealer in federal court trial.{{ FIELD }}Prosecuted trial claims on behalf of private country club related to $850,000 annual special assessment.{{ FIELD }}Prosecuted claims on behalf of Bahraini pharmaceutical company against US machinery supplier in arbitration.{{ FIELD }}Defended SEC claims against CEO of public company in federal court trial.{{ FIELD }}Defended breach of fiduciary duty claims against public company in connection with merger transaction.{{ FIELD }}Prosecuted several pro bono trials on behalf of prisoners alleging civil rights violations.{{ FIELD }}Internal Investigations\nRepresented audit committee of construction firm in connection with internal investigation arising from whistleblower allegations of accounting irregularities.\nInvestigated alleged stock-option backdating on behalf of audit committee of NASDAQ-traded public company in the telecommunications industry.\nInvestigated allegations of dishonest conduct by senior financial personnel of NYSE-traded public company in the telecommunications industry.\nRepresented audit committee of NYSE-traded public company in the real estate industry in two separate internal investigations arising from whistleblower allegations of accounting and other fraud.\nInvestigated accounting fraud allegations on behalf of audit committee of NASDAQ-traded company in the pharmaceutical industry.\nInvestigated inventory accounting fraud allegations for Amex-traded public company in the aerospace industry.\nInvestigated allegations of insider trading by officer of Nasdaq-traded bank holding company.{{ FIELD }}Securities Class Action Defense\nDefended federal class action securities claims against medical device manufacturer related to disclosures about the status of new product development. Dismissal affirmed on appeal.\nDefended public correctional facilities company in defense of federal securities claims related to COVID-19 and disclosures.\nDefended federal securities class action against VOIP telecommunications company.\nDefended federal class action securities claims against a public company in the education industry alleging accounting and other misstatements.\nDefended federal securities class action against staffing company.\nRepresented hedge fund and its principal in defense of securities class action and parallel derivative claims regarding stock buyback.\nDefended federal securities class action against semiconductor company alleging fraud in connection with revision to earnings guidance.\nDefended federal class action securities claims related to earnings miss by NYSE-traded solid waste disposal company.\nDefended federal class action securities claims against pharmaceutical company related to status of new product development.\nDefended federal class action securities claims related to earnings miss and alleged accounting improprieties for a software-development company.\nRepresented former CEO of bankrupt software company in multidistrict federal securities fraud litigation alleging accounting and related-party-disclosure improprieties.\nDefended Big 4 accounting firm in federal securities class action.\nRepresented aerospace company in defending federal class action securities claims alleging revenue recognition violations after restatement of five years’ financial statements.\nRepresented former controller of bankrupt time-share company in federal class action securities claims alleging accounting misstatements related to $130 million impairment charge.\nRepresented directors and officers of bankrupt telecommunications infrastructure company in federal class action securities claims alleging financial misstatements.{{ FIELD }}Antitakeover and M\u0026amp;A Litigation\nRepresented health insurance company in defense of claims seeking to enjoin $12.8 billion merger.\nDefeated preliminary injunction in Maryland litigation seeking to enjoin $84 million merger.\nRepresented sports merchandising company in defense of claims seeking to enjoin $185 million merger.\nRepresented private equity fund in litigation seeking to enjoin going-private transaction.\nRepresented healthcare company in litigation seeking to enjoin $1.1 billion merger transaction.\nDefended preliminary injunction proceeding in Florida state court regarding a $500 million merger for a public company in the security industry.\nDefended preliminary injunction regarding a $50 million public company merger.\nRepresented NASDAQ-traded physician services company regarding a $1.1 billion going-private merger.\nRepresented waste services company in defense of multistate litigation seeking to enjoin $6 billion merger involving an unsolicited hostile takeover bid.\nRepresented timeshare company in multi-state litigation seeking to enjoin stock-for-stock merger, involving hostile takeover bid.\nRepresented retailer in litigation seeking to enjoin $150 million merger transaction.\nRepresented acquiror of publicly traded correctional properties company in Maryland and Florida state-court actions seeking to enjoin $300 million merger.\nRepresented acquiror of health products distributor in Florida state-court class action seeking to enjoin acquisition of public company.\nAdvised management of companies considering hostile takeover of competitors.{{ FIELD }}SEC Enforcement Defense\nDefended multiple clients at trial against SEC charges.\nRepresented former CEO of software company in an SEC enforcement proceeding.\nRepresented Latin American investment company in defense of SEC enforcement proceeding relating to broker-dealer registration.\nRepresented private company in the direct marketing industry related to alleged market manipulation.\nRepresented aerospace company, in the face of related criminal proceedings against company’s CEO and CFO, related to alleged revenue recognition violations stemming from restatement of multiple years’ financial statements.\nRepresented former consultant to telecommunications equipment company in SEC investigation of alleged accounting improprieties.\nRepresented NYSE-traded company in SEC informal inquiry concerning disposition of European assets.\nRepresented former officer of nutrition supplement company in SEC investigation related to alleged revenue recognition issues.\nRepresented individuals in SEC investigation related to alleged Finders’ Fees.\nRepresented numerous individuals in SEC enforcement action related to alleged insider trading.\nRepresented certified public accountant in Rule 102(e) proceeding.\nRepresented broker-dealer in Florida state investigation regarding auction-rate securities.\nRepresented numerous public companies in SEC and SRO investigations of pre-announcement trading activity related to announced merger transactions.{{ FIELD }}Other Accounting and Financial Fraud Litigation\nRepresented crypto mining support company in novel antitrust claims related to Bitcoin.\nRepresented private equity fund in defense of multiple lawsuits in New York federal and state courts alleging fraudulent accounts receivable.\nDefended public companies in class actions alleging unfair and deceptive trade practices.\nRepresented directors of television broadcasting company in defense of claims brought by bankruptcy trustee.\nOpposed remand to state court for Internet company in suit seeking rescission by investors.\nRepresented Amex-traded public company in the pharmaceutical industry in federal court and arbitration against German company alleging accounting improprieties in connection with an earnout agreement.\nRepresented Central Bank of Ecuador in banking fraud litigation pending in The Bahamas.\nRepresented U.S. railroad in accounting arbitration related to shipping rates.\nRepresented receiver over $100 million assets in dispute regarding an educational institution in the Caribbean.{{ FIELD }}Other Shareholder Derivative Litigation Defense\nDefended executive of a private equity fund at trial in defense of derivative claims brought by investor related to M\u0026amp;A transactions.\nRepresented directors of a publicly traded entertainment company related to the acquisition of a business from an affiliate.\nRepresented public company in the education industry in defending derivative claims arising from parallel criminal and SEC investigations.\nRepresented directors and officers of private restaurant company in arbitration alleging mismanagement.{{ FIELD }}Lodging \u0026amp; Lifestyle\nRepresented private country club at trial against municipality.\nRepresented public vacation ownership (timeshare) company in defense of multi-jurisdiction state court class actions.\nRepresented hotel company in defense of federal class action and related derivative litigation.\nRepresented owners of condo hotel project in federal mass-action litigation against developer.\nRepresented online travel booking website in various matters.\nRepresented officer of public vacation ownership (timeshare) company in federal class action.\nRepresented Mexican restaurant chain in Texas state court litigation and arbitration.\nRepresented hotel company in litigation in Arizona state court.{{ FIELD }}Brian Miller focuses his practice on securities class action defense, SEC investigations, internal investigations of whistleblower allegations, accounting fraud, fiduciary duties, private credit disputes, partnership disputes, healthcare disputes, and other commercial disputes. Brian has defended dozens of shareholder class actions alleging securities fraud, accounting fraud, and breach of fiduciary duty. Collectively, these matters have sought damages in the billions of dollars. \nBrian represents public companies and their directors and officers, private equity and private credit funds, borrowers from private credit funds, registered investment advisors, and individual and corporate clients facing SEC investigations and bet-the-company litigation, typically involving fraud or breach of fiduciary duty allegations. He also has significant experience litigating commercial disputes throughout Florida, in state and federal courts as well as private arbitration tribunals. Many of his cases involve multiple related lawsuits and pending government or regulatory investigations in different jurisdictions across the United States and internationally.\nBrian draws upon his experience as a former SEC lawyer to represent his clients. Brian began his career at the SEC in Washington, D.C., where, among other things, he served as special counsel to Commissioner Steven M.H. Wallman. He is recognized annually by Benchmark Litigation and The Best Lawyers in America and is ranked Band 1 by Chambers USA in “Litigation: Securities – Florida”. Partner Ranked Band 1 Chambers USA in Litigation: Securities – Florida Recognized for Commercial Litigation and Litigation – Securities in Florida The Best Lawyers in America 2012-2021 Named a “Litigation Star” for General Commercial and Securities in Florida Benchmark Litigation 2014-2021, 2023 Recognized as a “Top Rated Securities Litigation Attorney in Miami, FL Super Lawyers Magazine 2009-2022 Walsh University  Case Western Reserve University Case Western Reserve University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Southern District of New York U.S. District Court for the Eastern District of Wisconsin U.S. District Court for the Middle District of Florida U.S. District Court for the Northern District of Florida U.S. District Court for the Southern District of Florida U.S. District Court for the District of Columbia District of Columbia Florida U.S. Bankruptcy Court for the Southern District of New York U.S. Bankruptcy Court for the Middle District of Florida Dade County Bar Association, Committee on Securities Litigation, Past Co-Chair Dade County Bar Association, Committee on Banking and Corporate Litigation, Past Co-Chair ACLU of Miami-Dade County, Legal Screening Panel, Member CHARLEE Homes for Children, Past Board Member Morningside Historic Education Society, Past Treasurer United Way of Miami-Dade Economic Mobility Oversight Council Member Federal Bar Association, Audit Committee Member 2025-2026 Legal Services of Greater Miami, Member of Leaders Council Representative Trial Experience\nDefended private equity fund against allegations of breach of fiduciary duty in a nine-week trial. Defended Latin American businessman on $30 million fraud and breach of promissory note claims in federal bankruptcy court trial. Defended SEC claims against alleged unregistered broker dealer in federal court trial. Prosecuted trial claims on behalf of private country club related to $850,000 annual special assessment. Prosecuted claims on behalf of Bahraini pharmaceutical company against US machinery supplier in arbitration. Defended SEC claims against CEO of public company in federal court trial. Defended breach of fiduciary duty claims against public company in connection with merger transaction. Prosecuted several pro bono trials on behalf of prisoners alleging civil rights violations. Internal Investigations\nRepresented audit committee of construction firm in connection with internal investigation arising from whistleblower allegations of accounting irregularities.\nInvestigated alleged stock-option backdating on behalf of audit committee of NASDAQ-traded public company in the telecommunications industry.\nInvestigated allegations of dishonest conduct by senior financial personnel of NYSE-traded public company in the telecommunications industry.\nRepresented audit committee of NYSE-traded public company in the real estate industry in two separate internal investigations arising from whistleblower allegations of accounting and other fraud.\nInvestigated accounting fraud allegations on behalf of audit committee of NASDAQ-traded company in the pharmaceutical industry.\nInvestigated inventory accounting fraud allegations for Amex-traded public company in the aerospace industry.\nInvestigated allegations of insider trading by officer of Nasdaq-traded bank holding company. Securities Class Action Defense\nDefended federal class action securities claims against medical device manufacturer related to disclosures about the status of new product development. Dismissal affirmed on appeal.\nDefended public correctional facilities company in defense of federal securities claims related to COVID-19 and disclosures.\nDefended federal securities class action against VOIP telecommunications company.\nDefended federal class action securities claims against a public company in the education industry alleging accounting and other misstatements.\nDefended federal securities class action against staffing company.\nRepresented hedge fund and its principal in defense of securities class action and parallel derivative claims regarding stock buyback.\nDefended federal securities class action against semiconductor company alleging fraud in connection with revision to earnings guidance.\nDefended federal class action securities claims related to earnings miss by NYSE-traded solid waste disposal company.\nDefended federal class action securities claims against pharmaceutical company related to status of new product development.\nDefended federal class action securities claims related to earnings miss and alleged accounting improprieties for a software-development company.\nRepresented former CEO of bankrupt software company in multidistrict federal securities fraud litigation alleging accounting and related-party-disclosure improprieties.\nDefended Big 4 accounting firm in federal securities class action.\nRepresented aerospace company in defending federal class action securities claims alleging revenue recognition violations after restatement of five years’ financial statements.\nRepresented former controller of bankrupt time-share company in federal class action securities claims alleging accounting misstatements related to $130 million impairment charge.\nRepresented directors and officers of bankrupt telecommunications infrastructure company in federal class action securities claims alleging financial misstatements. Antitakeover and M\u0026amp;A Litigation\nRepresented health insurance company in defense of claims seeking to enjoin $12.8 billion merger.\nDefeated preliminary injunction in Maryland litigation seeking to enjoin $84 million merger.\nRepresented sports merchandising company in defense of claims seeking to enjoin $185 million merger.\nRepresented private equity fund in litigation seeking to enjoin going-private transaction.\nRepresented healthcare company in litigation seeking to enjoin $1.1 billion merger transaction.\nDefended preliminary injunction proceeding in Florida state court regarding a $500 million merger for a public company in the security industry.\nDefended preliminary injunction regarding a $50 million public company merger.\nRepresented NASDAQ-traded physician services company regarding a $1.1 billion going-private merger.\nRepresented waste services company in defense of multistate litigation seeking to enjoin $6 billion merger involving an unsolicited hostile takeover bid.\nRepresented timeshare company in multi-state litigation seeking to enjoin stock-for-stock merger, involving hostile takeover bid.\nRepresented retailer in litigation seeking to enjoin $150 million merger transaction.\nRepresented acquiror of publicly traded correctional properties company in Maryland and Florida state-court actions seeking to enjoin $300 million merger.\nRepresented acquiror of health products distributor in Florida state-court class action seeking to enjoin acquisition of public company.\nAdvised management of companies considering hostile takeover of competitors. SEC Enforcement Defense\nDefended multiple clients at trial against SEC charges.\nRepresented former CEO of software company in an SEC enforcement proceeding.\nRepresented Latin American investment company in defense of SEC enforcement proceeding relating to broker-dealer registration.\nRepresented private company in the direct marketing industry related to alleged market manipulation.\nRepresented aerospace company, in the face of related criminal proceedings against company’s CEO and CFO, related to alleged revenue recognition violations stemming from restatement of multiple years’ financial statements.\nRepresented former consultant to telecommunications equipment company in SEC investigation of alleged accounting improprieties.\nRepresented NYSE-traded company in SEC informal inquiry concerning disposition of European assets.\nRepresented former officer of nutrition supplement company in SEC investigation related to alleged revenue recognition issues.\nRepresented individuals in SEC investigation related to alleged Finders’ Fees.\nRepresented numerous individuals in SEC enforcement action related to alleged insider trading.\nRepresented certified public accountant in Rule 102(e) proceeding.\nRepresented broker-dealer in Florida state investigation regarding auction-rate securities.\nRepresented numerous public companies in SEC and SRO investigations of pre-announcement trading activity related to announced merger transactions. Other Accounting and Financial Fraud Litigation\nRepresented crypto mining support company in novel antitrust claims related to Bitcoin.\nRepresented private equity fund in defense of multiple lawsuits in New York federal and state courts alleging fraudulent accounts receivable.\nDefended public companies in class actions alleging unfair and deceptive trade practices.\nRepresented directors of television broadcasting company in defense of claims brought by bankruptcy trustee.\nOpposed remand to state court for Internet company in suit seeking rescission by investors.\nRepresented Amex-traded public company in the pharmaceutical industry in federal court and arbitration against German company alleging accounting improprieties in connection with an earnout agreement.\nRepresented Central Bank of Ecuador in banking fraud litigation pending in The Bahamas.\nRepresented U.S. railroad in accounting arbitration related to shipping rates.\nRepresented receiver over $100 million assets in dispute regarding an educational institution in the Caribbean. Other Shareholder Derivative Litigation Defense\nDefended executive of a private equity fund at trial in defense of derivative claims brought by investor related to M\u0026amp;A transactions.\nRepresented directors of a publicly traded entertainment company related to the acquisition of a business from an affiliate.\nRepresented public company in the education industry in defending derivative claims arising from parallel criminal and SEC investigations.\nRepresented directors and officers of private restaurant company in arbitration alleging mismanagement. Lodging \u0026amp; Lifestyle\nRepresented private country club at trial against municipality.\nRepresented public vacation ownership (timeshare) company in defense of multi-jurisdiction state court class actions.\nRepresented hotel company in defense of federal class action and related derivative litigation.\nRepresented owners of condo hotel project in federal mass-action litigation against developer.\nRepresented online travel booking website in various matters.\nRepresented officer of public vacation ownership (timeshare) company in federal class action.\nRepresented Mexican restaurant chain in Texas state court litigation and arbitration.\nRepresented hotel company in litigation in Arizona state court.","searchable_name":"Brian P. Miller","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":430199,"version":1,"owner_type":"Person","owner_id":2057,"payload":{"bio":"\u003cp\u003ePatrick Montgomery represents global financial institutions and public companies in high-risk government and internal investigations and complex litigation. In particular, Patrick defends clients in the financial services, accounting, technology, and manufacturing sectors in white-collar criminal matters, SEC enforcement actions, and securities and shareholder litigation.\u0026nbsp;\u0026nbsp; He has extensive experience counseling clients facing investigations before the U.S. Department of Justice, Securities and Exchange Commission, State Attorneys General and other regulatory authorities.\u003c/p\u003e\n\u003cp\u003ePatrick also serves (pro bono) as General Counsel for the Ethics \u0026amp; Compliance Initiative, a non-profit organization committed to assisting public companies and other institutions in creating and sustaining high quality\u0026nbsp;ethics and compliance\u0026nbsp;programs throughout the world.\u003c/p\u003e\n\u003cp\u003eAdditionally, Patrick serves as the Deputy Co-head of King \u0026amp; Spalding's Financial Services industry team.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePatrick is recognized in\u0026nbsp;\u003cem\u003eLegal 500\u0026nbsp;\u003c/em\u003efor his work in Antitrust: Civil Litigation/Class Actions.\u003c/p\u003e\n\u003cp\u003eHe started his career as an associate at King \u0026amp; Spalding before practicing for eight years at another AmLaw 50 law firm.\u003c/p\u003e\n\u003cp\u003eAfter graduating from law school, Patrick clerked for the Honorable Jane R. Roth on the United States Court of Appeals for the Third Circuit.\u003c/p\u003e","slug":"patrick-montgomery","email":"pmontgomery@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting a leading defense contractor in connection with a False Claims Act investigation.\u003c/p\u003e","\u003cp\u003eRepresenting a global financial institution in connection with a grand jury subpoena.\u003c/p\u003e","\u003cp\u003eRepresenting a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eGovernment \u0026amp; Internal Investigation Matters\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eCounsel to financial institution in Massachusetts Attorney General investigation into certain practices related to collateralized loan obligations (CLO)\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in investigations being conducted by numerous domestic and foreign regulatory authorities involving the benchmark WM/Reuters currency exchange rate\u003c/p\u003e","\u003cp\u003eCounsel to public company in an SEC investigation into potential accounting and disclosure violations related to revenue recognition\u003c/p\u003e","\u003cp\u003eCounsel to leading accounting firm in an SEC investigation into potential accounting misconduct by one of its financial institution audit clients, and possible associated audit failures\u003c/p\u003e","\u003cp\u003eCounsel to public company in an SEC investigation into possible insider trading arising from a corporate takeover\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in NYSE investigation into certain trading practices\u003c/p\u003e","\u003cp\u003eCounsel to collateral manager of a leading fixed-income asset manager in an SEC investigation into sales practices relating to asset-backed and synthetic collateralized debt obligations (CDO) and associated credit default swaps\u003c/p\u003e","\u003cp\u003eCounsel to publicly-traded company's board of directors in connection with FCPA-related internal investigations and government enforcement actions involving the U.S. Department of Justice and the SEC\u003c/p\u003e","\u003cp\u003eCounsel to private equity firm and its senior executives in an SEC investigation into potential breach of fiduciary duty, self-dealing and related-party transactions\u003c/p\u003e","\u003cp\u003e\u003cem\u003eLitigation Matters\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eDefeated class certification on behalf of global financial institution in action brought in the U.S. District Court for the Southern District of New York alleging the client delayed execution of e-Trading foreign exchange orders to take advantage of market movements in its favor\u003c/p\u003e","\u003cp\u003eRepresenting a global bank in connection with alleged fraudulent transfer claims in connection with the Bernard Madoff SIPA proceedings (S.D.N.Y.)\u003c/p\u003e","\u003cp\u003eSuccessfully resolved dispute on behalf of group of investors in Delaware Chancery Court against allegations of breaches of fiduciary duty of disclosure and loyalty in connection with all-cash acquisition\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in federal antitrust class actions alleging that foreign currency dealers conspired to manipulate the benchmark WM/Reuters currency exchange rate. Three of the putative class actions were dismissed and one was voluntarily discontinued after pre-motion conference\u003c/p\u003e","\u003cp\u003eRepresenting a global financial institution in connection with multiple putative class actions asserting antitrust, RICO, CEA and common law claims based on alleged manipulation of USD LIBOR, Yen LIBOR, the Singapore Interbank Offered Rate, and the Australian Bank Bill Swap Rate\u003c/p\u003e","\u003cp\u003eRepresented CEO of Fortune 10 company in securities class action, shareholder derivative litigation and Delaware Section 220 books and records action\u003c/p\u003e","\u003cp\u003eCounsel to newly public technology company and its officers and directors in defense of dozens of securities class actions and shareholder derivative lawsuits in courts around the country following one of the largest initial public offerings in history\u003c/p\u003e","\u003cp\u003eWon summary judgment on behalf of leading private equity firm in defense of putative class action alleging failure to provide sixty-day notice of a mass layoff under the Federal and New Jersey WARN Acts. Trial court order affirmed by the U.S. Court of Appeals for the Third Circuit\u003c/p\u003e","\u003cp\u003eDefense of automotive headlight manufacturer in suit claiming false advertising, fraud and misrepresentation in connection with promotional materials and packaging for certain headlight brands\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in New York state court proceeding alleging breach of contract and related claims arising from a real estate lending transaction\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":1,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":2,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":766,"guid":"766.smart_tags","index":5,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":6,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":7,"source":"smartTags"},{"id":19,"guid":"19.capabilities","index":8,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":9,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":10,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":11,"source":"smartTags"},{"id":1165,"guid":"1165.smart_tags","index":12,"source":"smartTags"},{"id":122,"guid":"122.capabilities","index":13,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":14,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":15,"source":"smartTags"},{"id":1197,"guid":"1197.smart_tags","index":16,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":17,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":18,"source":"capabilities"},{"id":1261,"guid":"1261.smart_tags","index":19,"source":"smartTags"},{"id":803,"guid":"803.smart_tags","index":20,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":21,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":22,"source":"capabilities"}],"is_active":true,"last_name":"Montgomery","nick_name":"Patrick","clerkships":[{"name":"Law Clerk, Hon. Jane R. Roth, U.S. Court of Appeals for the Third Circuit","years_held":"2011 - 2011"}],"first_name":"Patrick","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Patrick is recognized for his work in Corporate investigations and white-collar criminal defense: advice to corporates","detail":"Legal 500 USA 2024"},{"title":"Patrick has also been recognized in Legal 500 for his work in Antitrust: Civil Litigation/Class Actions","detail":"Legal 500"}],"linked_in_url":"https://www.linkedin.com/in/patrick-montgomery-4928ab5/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003ePatrick Montgomery represents global financial institutions and public companies in high-risk government and internal investigations and complex litigation. In particular, Patrick defends clients in the financial services, accounting, technology, and manufacturing sectors in white-collar criminal matters, SEC enforcement actions, and securities and shareholder litigation.\u0026nbsp;\u0026nbsp; He has extensive experience counseling clients facing investigations before the U.S. Department of Justice, Securities and Exchange Commission, State Attorneys General and other regulatory authorities.\u003c/p\u003e\n\u003cp\u003ePatrick also serves (pro bono) as General Counsel for the Ethics \u0026amp; Compliance Initiative, a non-profit organization committed to assisting public companies and other institutions in creating and sustaining high quality\u0026nbsp;ethics and compliance\u0026nbsp;programs throughout the world.\u003c/p\u003e\n\u003cp\u003eAdditionally, Patrick serves as the Deputy Co-head of King \u0026amp; Spalding's Financial Services industry team.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePatrick is recognized in\u0026nbsp;\u003cem\u003eLegal 500\u0026nbsp;\u003c/em\u003efor his work in Antitrust: Civil Litigation/Class Actions.\u003c/p\u003e\n\u003cp\u003eHe started his career as an associate at King \u0026amp; Spalding before practicing for eight years at another AmLaw 50 law firm.\u003c/p\u003e\n\u003cp\u003eAfter graduating from law school, Patrick clerked for the Honorable Jane R. Roth on the United States Court of Appeals for the Third Circuit.\u003c/p\u003e","matters":["\u003cp\u003eRepresenting a leading defense contractor in connection with a False Claims Act investigation.\u003c/p\u003e","\u003cp\u003eRepresenting a global financial institution in connection with a grand jury subpoena.\u003c/p\u003e","\u003cp\u003eRepresenting a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eGovernment \u0026amp; Internal Investigation Matters\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eCounsel to financial institution in Massachusetts Attorney General investigation into certain practices related to collateralized loan obligations (CLO)\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in investigations being conducted by numerous domestic and foreign regulatory authorities involving the benchmark WM/Reuters currency exchange rate\u003c/p\u003e","\u003cp\u003eCounsel to public company in an SEC investigation into potential accounting and disclosure violations related to revenue recognition\u003c/p\u003e","\u003cp\u003eCounsel to leading accounting firm in an SEC investigation into potential accounting misconduct by one of its financial institution audit clients, and possible associated audit failures\u003c/p\u003e","\u003cp\u003eCounsel to public company in an SEC investigation into possible insider trading arising from a corporate takeover\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in NYSE investigation into certain trading practices\u003c/p\u003e","\u003cp\u003eCounsel to collateral manager of a leading fixed-income asset manager in an SEC investigation into sales practices relating to asset-backed and synthetic collateralized debt obligations (CDO) and associated credit default swaps\u003c/p\u003e","\u003cp\u003eCounsel to publicly-traded company's board of directors in connection with FCPA-related internal investigations and government enforcement actions involving the U.S. Department of Justice and the SEC\u003c/p\u003e","\u003cp\u003eCounsel to private equity firm and its senior executives in an SEC investigation into potential breach of fiduciary duty, self-dealing and related-party transactions\u003c/p\u003e","\u003cp\u003e\u003cem\u003eLitigation Matters\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eDefeated class certification on behalf of global financial institution in action brought in the U.S. District Court for the Southern District of New York alleging the client delayed execution of e-Trading foreign exchange orders to take advantage of market movements in its favor\u003c/p\u003e","\u003cp\u003eRepresenting a global bank in connection with alleged fraudulent transfer claims in connection with the Bernard Madoff SIPA proceedings (S.D.N.Y.)\u003c/p\u003e","\u003cp\u003eSuccessfully resolved dispute on behalf of group of investors in Delaware Chancery Court against allegations of breaches of fiduciary duty of disclosure and loyalty in connection with all-cash acquisition\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in federal antitrust class actions alleging that foreign currency dealers conspired to manipulate the benchmark WM/Reuters currency exchange rate. Three of the putative class actions were dismissed and one was voluntarily discontinued after pre-motion conference\u003c/p\u003e","\u003cp\u003eRepresenting a global financial institution in connection with multiple putative class actions asserting antitrust, RICO, CEA and common law claims based on alleged manipulation of USD LIBOR, Yen LIBOR, the Singapore Interbank Offered Rate, and the Australian Bank Bill Swap Rate\u003c/p\u003e","\u003cp\u003eRepresented CEO of Fortune 10 company in securities class action, shareholder derivative litigation and Delaware Section 220 books and records action\u003c/p\u003e","\u003cp\u003eCounsel to newly public technology company and its officers and directors in defense of dozens of securities class actions and shareholder derivative lawsuits in courts around the country following one of the largest initial public offerings in history\u003c/p\u003e","\u003cp\u003eWon summary judgment on behalf of leading private equity firm in defense of putative class action alleging failure to provide sixty-day notice of a mass layoff under the Federal and New Jersey WARN Acts. Trial court order affirmed by the U.S. Court of Appeals for the Third Circuit\u003c/p\u003e","\u003cp\u003eDefense of automotive headlight manufacturer in suit claiming false advertising, fraud and misrepresentation in connection with promotional materials and packaging for certain headlight brands\u003c/p\u003e","\u003cp\u003eCounsel to global financial institution in New York state court proceeding alleging breach of contract and related claims arising from a real estate lending transaction\u003c/p\u003e"],"recognitions":[{"title":"Patrick is recognized for his work in Corporate investigations and white-collar criminal defense: advice to corporates","detail":"Legal 500 USA 2024"},{"title":"Patrick has also been recognized in Legal 500 for his work in Antitrust: Civil Litigation/Class Actions","detail":"Legal 500"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6186}]},"capability_group_id":2},"created_at":"2025-06-12T20:54:22.000Z","updated_at":"2025-06-12T20:54:22.000Z","searchable_text":"Montgomery{{ FIELD }}{:title=\u0026gt;\"Patrick is recognized for his work in Corporate investigations and white-collar criminal defense: advice to corporates\", :detail=\u0026gt;\"Legal 500 USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Patrick has also been recognized in Legal 500 for his work in Antitrust: Civil Litigation/Class Actions\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}Representing a leading defense contractor in connection with a False Claims Act investigation.{{ FIELD }}Representing a global financial institution in connection with a grand jury subpoena.{{ FIELD }}Representing a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.{{ FIELD }}Government \u0026amp; Internal Investigation Matters{{ FIELD }}Counsel to financial institution in Massachusetts Attorney General investigation into certain practices related to collateralized loan obligations (CLO){{ FIELD }}Counsel to global financial institution in investigations being conducted by numerous domestic and foreign regulatory authorities involving the benchmark WM/Reuters currency exchange rate{{ FIELD }}Counsel to public company in an SEC investigation into potential accounting and disclosure violations related to revenue recognition{{ FIELD }}Counsel to leading accounting firm in an SEC investigation into potential accounting misconduct by one of its financial institution audit clients, and possible associated audit failures{{ FIELD }}Counsel to public company in an SEC investigation into possible insider trading arising from a corporate takeover{{ FIELD }}Counsel to global financial institution in NYSE investigation into certain trading practices{{ FIELD }}Counsel to collateral manager of a leading fixed-income asset manager in an SEC investigation into sales practices relating to asset-backed and synthetic collateralized debt obligations (CDO) and associated credit default swaps{{ FIELD }}Counsel to publicly-traded company's board of directors in connection with FCPA-related internal investigations and government enforcement actions involving the U.S. Department of Justice and the SEC{{ FIELD }}Counsel to private equity firm and its senior executives in an SEC investigation into potential breach of fiduciary duty, self-dealing and related-party transactions{{ FIELD }}Litigation Matters{{ FIELD }}Defeated class certification on behalf of global financial institution in action brought in the U.S. District Court for the Southern District of New York alleging the client delayed execution of e-Trading foreign exchange orders to take advantage of market movements in its favor{{ FIELD }}Representing a global bank in connection with alleged fraudulent transfer claims in connection with the Bernard Madoff SIPA proceedings (S.D.N.Y.){{ FIELD }}Successfully resolved dispute on behalf of group of investors in Delaware Chancery Court against allegations of breaches of fiduciary duty of disclosure and loyalty in connection with all-cash acquisition{{ FIELD }}Counsel to global financial institution in federal antitrust class actions alleging that foreign currency dealers conspired to manipulate the benchmark WM/Reuters currency exchange rate. Three of the putative class actions were dismissed and one was voluntarily discontinued after pre-motion conference{{ FIELD }}Representing a global financial institution in connection with multiple putative class actions asserting antitrust, RICO, CEA and common law claims based on alleged manipulation of USD LIBOR, Yen LIBOR, the Singapore Interbank Offered Rate, and the Australian Bank Bill Swap Rate{{ FIELD }}Represented CEO of Fortune 10 company in securities class action, shareholder derivative litigation and Delaware Section 220 books and records action{{ FIELD }}Counsel to newly public technology company and its officers and directors in defense of dozens of securities class actions and shareholder derivative lawsuits in courts around the country following one of the largest initial public offerings in history{{ FIELD }}Won summary judgment on behalf of leading private equity firm in defense of putative class action alleging failure to provide sixty-day notice of a mass layoff under the Federal and New Jersey WARN Acts. Trial court order affirmed by the U.S. Court of Appeals for the Third Circuit{{ FIELD }}Defense of automotive headlight manufacturer in suit claiming false advertising, fraud and misrepresentation in connection with promotional materials and packaging for certain headlight brands{{ FIELD }}Counsel to global financial institution in New York state court proceeding alleging breach of contract and related claims arising from a real estate lending transaction{{ FIELD }}Patrick Montgomery represents global financial institutions and public companies in high-risk government and internal investigations and complex litigation. In particular, Patrick defends clients in the financial services, accounting, technology, and manufacturing sectors in white-collar criminal matters, SEC enforcement actions, and securities and shareholder litigation.   He has extensive experience counseling clients facing investigations before the U.S. Department of Justice, Securities and Exchange Commission, State Attorneys General and other regulatory authorities.\nPatrick also serves (pro bono) as General Counsel for the Ethics \u0026amp; Compliance Initiative, a non-profit organization committed to assisting public companies and other institutions in creating and sustaining high quality ethics and compliance programs throughout the world.\nAdditionally, Patrick serves as the Deputy Co-head of King \u0026amp; Spalding's Financial Services industry team.\nPatrick is recognized in Legal 500 for his work in Antitrust: Civil Litigation/Class Actions.\nHe started his career as an associate at King \u0026amp; Spalding before practicing for eight years at another AmLaw 50 law firm.\nAfter graduating from law school, Patrick clerked for the Honorable Jane R. Roth on the United States Court of Appeals for the Third Circuit. Partner Patrick is recognized for his work in Corporate investigations and white-collar criminal defense: advice to corporates Legal 500 USA 2024 Patrick has also been recognized in Legal 500 for his work in Antitrust: Civil Litigation/Class Actions Legal 500 College of the Holy Cross  Georgetown University Georgetown University Law Center U.S. Court of Appeals for the Third Circuit U.S. District Court for the Southern District of New York U.S. District Court for the Northern District of Georgia U.S. District Court for the District of Columbia District of Columbia Georgia Court of Appeals of Georgia Law Clerk, Hon. Jane R. Roth, U.S. Court of Appeals for the Third Circuit Representing a leading defense contractor in connection with a False Claims Act investigation. Representing a global financial institution in connection with a grand jury subpoena. Representing a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor. Government \u0026amp; Internal Investigation Matters Counsel to financial institution in Massachusetts Attorney General investigation into certain practices related to collateralized loan obligations (CLO) Counsel to global financial institution in investigations being conducted by numerous domestic and foreign regulatory authorities involving the benchmark WM/Reuters currency exchange rate Counsel to public company in an SEC investigation into potential accounting and disclosure violations related to revenue recognition Counsel to leading accounting firm in an SEC investigation into potential accounting misconduct by one of its financial institution audit clients, and possible associated audit failures Counsel to public company in an SEC investigation into possible insider trading arising from a corporate takeover Counsel to global financial institution in NYSE investigation into certain trading practices Counsel to collateral manager of a leading fixed-income asset manager in an SEC investigation into sales practices relating to asset-backed and synthetic collateralized debt obligations (CDO) and associated credit default swaps Counsel to publicly-traded company's board of directors in connection with FCPA-related internal investigations and government enforcement actions involving the U.S. Department of Justice and the SEC Counsel to private equity firm and its senior executives in an SEC investigation into potential breach of fiduciary duty, self-dealing and related-party transactions Litigation Matters Defeated class certification on behalf of global financial institution in action brought in the U.S. District Court for the Southern District of New York alleging the client delayed execution of e-Trading foreign exchange orders to take advantage of market movements in its favor Representing a global bank in connection with alleged fraudulent transfer claims in connection with the Bernard Madoff SIPA proceedings (S.D.N.Y.) Successfully resolved dispute on behalf of group of investors in Delaware Chancery Court against allegations of breaches of fiduciary duty of disclosure and loyalty in connection with all-cash acquisition Counsel to global financial institution in federal antitrust class actions alleging that foreign currency dealers conspired to manipulate the benchmark WM/Reuters currency exchange rate. Three of the putative class actions were dismissed and one was voluntarily discontinued after pre-motion conference Representing a global financial institution in connection with multiple putative class actions asserting antitrust, RICO, CEA and common law claims based on alleged manipulation of USD LIBOR, Yen LIBOR, the Singapore Interbank Offered Rate, and the Australian Bank Bill Swap Rate Represented CEO of Fortune 10 company in securities class action, shareholder derivative litigation and Delaware Section 220 books and records action Counsel to newly public technology company and its officers and directors in defense of dozens of securities class actions and shareholder derivative lawsuits in courts around the country following one of the largest initial public offerings in history Won summary judgment on behalf of leading private equity firm in defense of putative class action alleging failure to provide sixty-day notice of a mass layoff under the Federal and New Jersey WARN Acts. Trial court order affirmed by the U.S. Court of Appeals for the Third Circuit Defense of automotive headlight manufacturer in suit claiming false advertising, fraud and misrepresentation in connection with promotional materials and packaging for certain headlight brands Counsel to global financial institution in New York state court proceeding alleging breach of contract and related claims arising from a real estate lending transaction","searchable_name":"Patrick Montgomery","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}